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Introduction
The concept of neuroglia was first proposed by Rudolf Virchow in 1858, in reference to the cellular elements that make up the connective tissue of the brain "nervekitt". The Müller cell was described as a radial fibre in the retina by Heinrich Müller in 1851, later becoming known as Müller glial cells. In 1893, the term astrocyte first appeared, used by Michael von Lenhossek in reference to the stellate morphology (from the Greek for star, astro, and cell, cyte) of the cells that Camillo Golgi had previously seen in the nervous system, describing them as the "glue" of the brain. These cells were soon subdivided into fibrous and protoplasmic astrocytes by Kolliker and Andriezen, yet their true diversity was not fully appreciated until Ramon y Cajal's drawings revealed their extraordinary pleomorphism. Based on his histological studies, several roles for this diverse class of cells were postulated, including a role in the maintenance of brain architecture, homeostasis and nutrition. In 1919, oligodendrocytes (from the Greek for few, oligo, branches, dendro, and cell cyte) and microglia were recognized as separated cell types and categorised as neuroglia by Pio del Rio-Hortega, one of the first scientists to propose that microglia are of mesodermal origin, and that they can migrate and act as phagocytes (Kettenmann and Verkhratsky, 2008) .
The vertebrate retina contains four types of glia, each of which exhibits distinct morphological, developmental and antigenic characteristics. Müller cells are the most predominant glial element, followed by astrocytes and microglia. The fourth glial cell type, the oligodendrocyte, is seen only occasionally in the retina, associated with myelinated ganglion cell axons in a few species like the rabbit. In this review, we will focus on general aspects of the mammalian retina and thus, we will not mention oligodendrocytes, even though their activity and interactions with other astrocytes in the optic nerve, and with retinal ganglion cell (RGC) axons, might affect retinal function in some species (Fig. 1) .
Despite studying the glia for more than a century the full influence of glial cells on neuronal centres is still not fully clear. While Cajal and others postulated several roles for glial cells (including maintaining brain architecture, homoeostasis, nutrition and regulating neuronal communication), we now know that glia are involved in many other roles within the nervous system, for example influencing synaptic connectivity by controlling the genesis and maintenance of synapses, and by modifying synaptic strength and plasticity. Although Müller, astrocytes and microglial cells each have a different developmental origin, they share many functions within the retina. Some of these activities are performed simultaneously, while others are carried out by one or other of the glial cell types. More recently glial cells have been established as a source of progenitors in the brain, as not only can radial glia act as pluripotent neural precursors but also, some astrocytes can re-enter the cell cycle and produce all types of brain cells, from neurons to macroglial cells.
It is known that glial cells have intrinsic signalling systems that can spread in the form of Ca 2þ waves and that are correlated with glutamate release. Among other functions, this signalling plays an important role in immunity, angiogenesis and neuroprotection. However, while neuroglia responds to injury as part of the defence to restore homeostasis, when they malfunction, these cells become what can be considered a primary pathogenic element. Little is known about the regulation of gliaeglia and gliaeneuronal interactions within the retina. However, since the retina is a well structured organ within the Central Nervous System (CNS), studies of the different roles of glial cells in health and disease have allowed researchers to understand some of their interactions with neurons. The interactions between glia and neurons contribute to retinal homeostasis, and while some such interactions have been defined, we are still far from fully understanding how homeostasis is maintained in the retina. Thus, in this review we will establish some of the common features of glial cells in the retina and we will describe their possible interactions with neurons.
Origin and morphology of the retinal glial cells

Müller cells
Origin and morphology of Müller cells
The Müller cell is the predominant glial element in the retina, representing 90% of the retinal glia. These are radially oriented cells that traverse the retina from its inner (vitreal) border to the distal end of the outer nuclear layer (ONL: Fig. 2 ). Although Müller cells share a lineage with retinal neurons, their time of birth appears to be different. Recent studies found the surprising origin of Müller cells in the neural crest cell (Liu et al., 2014a) . Birth dating of retinal neurons and Müller cells was determined by 3 H-thymidine-labelling (Sidman, 1961 ) and all retinal cell types are generated in an orderly fashion, the sequence of which is largely conserved among vertebrates (Vecino and Acera, 2015) . Accordingly, ganglion cells are the first cells to be born, followed closely by horizontal cells, cones and displaced amacrine cells. At later stages, amacrine cells, bipolar cells, rod cells and Müller cells are generated, and indeed, the general consensus is that Müller cells are the last cells to become post-mitotic (Cepko, 1993) . The idea of a functional unit in which local interactions occur between a group of retinal neurons and their supportive glial cell gave rise to the proposal of co-operativity among cells. This idea was based on developmental studies, where Müller cells were thought to perform many of the metabolic, ionic and extracellular buffering requirements of neurons, with which they share a common progenitor (Turner and Cepko, 1987) . Later, an interesting concept arose suggesting that co-operativity exists among cells that arise from a common stem cell to form a columnar array (Reichenbach et al., 1993) . The idea is that the retina is constituted by many functional units in which local interactions occur between the group of retinal neurons and their supportive Müller glial cell, limiting the sphere of influence of the latter. Thus, each Müller cell may only have to meet the requirements of its immediate neighbours for the extracellular environment to remain stable in the face of intense neural activity.
In retinal sections, the processes of Müller cells are seen to ensheath the cell bodies and processes of retinal neurons, especially after retinal damage (Hernandez et al., 2010) . Thus, it seems likely that the intimate association between these two cell types enables glial cells to promote the formation of synapses, and it would help maintain neuronal function by providing the nerve terminals with energy substrates and neurotransmitter precursors (Pfrieger and Barres, 1996) . Ensheathing by Müller cells is only possible to observe when membrane markers, like low affinity receptor p75, are used to stain the Müller cells, as it is not evident with cytoskeletal markers (Fig. 3) . As there are no specific astrocyte membrane markers, and GFAP (glial fibrillary acidic protein) and p75 co-localize in both Müller cells and astrocytes, it is possible that at least some of the ensheathing membranes around RGCs could belong to astrocytes. Moreover, in some species like dogs, the RGC axons are packaged and intercalated between the end feet of groups of Müller cells on their way to the optic nerve, forming a nest like structure. By contrast, in species like the pig or minipig, the RGC axons are intercalated between the Müller cells and such axonal packages are not found (Fig. 2) .
Although Müller cells from different species vary considerably in shape, they do have some fairly universal features. At the level of the outer limiting membrane (OLM), two processes extend in opposite directions and Müller cells extend apical microvilli into the sub-retinal space between the inner segments of photoreceptor cells. The length and number of microvilli may vary between species, probably in an inverse relationship to the degree of retinal vascularisation (Uga and Smelser, 1973) , and in some species Müller cells also possess a cilium (Ennis and Kunz, 1986) . In the opposite direction, the inner process approaches the vitreal surface of the neuroretina, forming a so-called endfoot that abuts the basal lamina between the vitreous body and the neuroretina (the "inner limiting membrane", ILM). In the nuclear layers, the lamellar processes of Müller cells form structures that envelop the cell bodies of neuronal cells (Dreher et al., 1992; Hama et al., 1978; Reichenbach et al., 1988 Reichenbach et al., , 1989 . In addition, Müller cells are involved in the structural organization of the blooderetina barrier . Blood capillaries are ensheathed by Müller cell processes that act as a communication system for metabolic exchange between the vasculature and neurons, in much the same manner as postulated for brain astrocytes (Fig. 2D) . However, the close physical association between Müller cell processes and retinal vessels still leaves open the possibility that the Müller cell per se is an essential component of the blooderetina barrier, and as such, it may be capable of influencing its own permeability (Sarthy and Ripps, 2001) .
In summary, the Müller cell population accumulates in a dense, regular pattern, although each cells can be considered as the core of a columnar retinal "microunit" of neurons . This "strategic position" enables Müller cells to constitute an anatomical and functional link between retinal neurons and the compartments with which these need to exchange molecules, i.e.: (Mi) , rods (R), cones (C). Note the location of the different layers of the retina (from the most internal to the outer layers): optic nerve (ON), nerve fibre layer (NFL), ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer (ONL), outer segment layer (OS), pigment epithelium (PE), choroid (Ch).
retinal blood vessels, the vitreous chamber and the sub-retinal space. Accordingly, Müller glia fulfil many crucial roles, supporting neuronal development, survival and information processing Sarthy and Ripps, 2001 ).
Müller cell markers
Müller cells can be easily identified by their characteristic morphology, containing a well-developed endoplasmic reticulum with varying amounts of glycogen granules (Hogan et al., 1971) . A prominent number of mitochondria are found at the endfeet (Fig. 3) . Müller cells can be labelled in living retinal preparations by loading for a few minutes with vital dyes, such as Mitotracker orange or CellTracker green. Their nuclei can be stained with ethidium bromide, diamidino yellow or chromomycin A3, which selectively penetrate Müller cells and have a marked affinity for nucleic acids (Jeon and Masland, 1993; Laties, 1983) . In culture, Müller cell nuclei can be differentiated, as they are the largest of the different retinal cell types.
In terms of immunohistochemical markers, the expression of various proteins is restricted to astrocytes and Müller cells, like vimentin and glial fibrillary acidic protein (GFAP), or selectively to Müller cells, such as the cellular retinaldehyde-binding protein (CRALBP), the glutamate-aspartate transporter (GLAST), glutamine synthetase (GS), the Kir4.1 subtype of inwardly rectifying potassium channels, aquaporin-4 (AQ4), pyruvate carboxylase, a-crystallin, the small GTP-binding protein RhoB, glutamate carboxypeptidase II, carbonic anhydrase C and microtubuleassociated protein 4 (Berger et al., 1999 ; Bunt-Milam and Saari, 1983; Linser and Moscona, 1981; Moscona et al., 1985; Parysek et al., 1985; Santos-Bredariol et al., 2006) .
Astrocytes
Origin and morphology of astrocytes
Named on the basis of their stellate shape, astrocytes are almost exclusively confined to the innermost retinal layers. The astrocytes in the retina do not originate from the retinal embryonic epithelium and thus, it is generally believed that these astrocytes migrate from the optic nerve and probably enter the retina along with the blood vessels (Stone and Dreher, 1987; Turner and Cepko, 1987; Watanabe and Raff, 1988) . In the optic nerve, as in other white matter tracts, most astrocytes and oligodendrocytes are derived from local mitoses (Skoff, 1990) . The ventricular cavity disappears in the evagination that forms the retina and optic nerve, and it is believed that the mitotic precursors of the oligodendrocytes and astrocytes migrate into the optic nerve from the sub-ependymal germinal layer of the brain. According to the extent of myelination, there would appear to be species differences in the migration of oligodendrocyte precursors. Thus, myelination stops at the lamina cribosa in the human and rat, while in rabbit and dog myelination extends beyond the lamina cribosa to reach the optic nerve head. In some fish, where the lamina cribosa is absent, myelination extends into the retina within the optic fibre layer (Wolburg, 1981) .
The presence and distribution of retinal astrocytes is correlated with the presence and distribution of retina blood vessels (Fig. 4) . Thus, while avascular retinas contain no astrocytes, they are distributed diffusely in those that are diffusely vascularized and restricted to the vascularised regions of other retinas. This striking correlation between vascularisation and the presence of astrocytes led to the proposal that retinal astrocytes are immigrants that enter the retina with its vasculature. While astrocytes may reside in almost all regions of the retina, regional differences in their density arise. Astrocytes are absent in retinal regions with extremely thin nerve fibre layers, such as areas near the ora serrata, and they are absent from the fovea centralis and the peri-foveolar retina of primates. Moreover, the periphery of the retina has a thin nerve fibre layer and it contains only a few dispersed astrocytes, the number of which increases as the nerve fibre layer thickens. Astrocytes send processes to both blood vessels and axons. Two groups of astrocytes can be distinguished in the pig and minipig retinas, those that are directly connected with blood vessels and those that seem to be connected with RGC axons. We found elongated astrocytes and star-shaped astrocytes similar to those first described in primates by Ogden (1978) . By contrast, in rat and mice we only found star-shaped astrocytes as described in other species (Fig. 5) .
The numbers and distribution of astrocytes depends on the density of the nerve fibres that they ensheath, as confirmed by confocal microscopy and computer-assisted image reconstruction of astrocytes in the vascularised retina of pigs, rats and mice (Rungger-Brandle et al., 1993) , and in the disposition of astrocytes between species (Fig. 5 ). For example, in the fully vascularised retina of cat, astrocytes are distributed throughout the inner retina in a pattern that closely mirrors that of the axon bundles (Karschin et al., 1986) . The reconstruction of images from retinas stained for GFAP (astrocytes) allowed us to visualize the ensheathing of blood vessels (Figs. 4B and 5A) , whereby the vitreal and lateral sides of most blood vessels are in close apposition to the vitreal surface of the retina. In addition, individual astrocytes can be seen to extend their processes into the vessel wall in such confocal images, especially in pig retinas, and while in some instances astrocytic processes extend to the vitreo-retinal surface, in other cases astrocytes remain parallel to RGC axons. It is noteworthy that astrocytes communicate by gap junctions, and that both vitreous and blood vessels can serve as a "sink" for K þ (Newman et al., 1984) .
Astrocyte markers
Astrocytic process envelops blood vessels as seen in electron microscopy, with apparently no perivascular space between the adventitia of the vessel wall and the glial cells (Hogan and Feeney, 1963; Hogan et al., 1971) . GFAP is the major constituent of the astrocytic intermediate filament (Bignami et al., 1972) , and it represents a reliable marker to identify and localise astrocytes in the mammalian retina. Under normal circumstances macroglia and mammalian Müller cells contain significant amounts of GFAP and thus, astrocytes must be classified as one of two distinct types in the retina by attending to other molecular markers: type I astrocytes express GFAP and connexin-43. Whereas type II astrocytes express GFAP but not connexin-43. Type I astrocytes can be further divided into type Ia and type Ib, the former present in the optic nerve head while type Ib astrocytes are present in the ILM of the retina (Hernandez et al., 2000) . Interestingly, both types are quiescent astrocytes and they only become reactive in response to certain stimuli, including elevated intraocular pressure, excitotoxicity and retinal ischemia (Hernandez et al., 2008) . When astrocytes become reactive they hypertrophy and enlarge their soma, they develop thicker astrocytic processes and their GFAPimmunoreactivity is enhanced.
Astrocytes main functions
Despite our increased understanding of the function of intermediate filaments (IFs) in astroglial cells (for a review, see Pekny, 2001) , the role of astroglial IFs in maintaining the mechanical integrity of these cells and that of the CNS tissue remains unclear. As the main producers of VEGF (vascular endothelial growth factor) during both normal (Stone et al., 1995) and pathological (Ozaki et al., 2000) vessel formation, astroglial cells are strongly implicated in retinal vascularisation. However, the vascular system develops normally in GFAP e/e ;Vim e/e mice, and VEGF RNA is expressed at normal levels in both ischemic and control GFAP ; Vim e/e mice.
These data support the hypothesis that mature astrocytes represent a key barrier to CNS axon regeneration in vivo (Cho et al., 2005) and thus, astrocytes may play dual roles: one beneficial and another degenerative. Some of the beneficial roles fulfilled by astrocytes include neurotrophic support, enhanced mechanical support for degenerating axons, and the maintenance of the blooderetina barrier. In response to injury or disease, the same astrocytes express a number of proteins that compromise the integrity of blooderetina barrier, up-regulating the expression of various genes encoding cytokines, chemokines and elements of the complement cascade, and promoting retinal degeneration (Anderson et al., 1967; Kim et al., 2006) . Reactive astrocytes in the retina express increased levels of MMP-9 and uPA, and accordingly, they degrade the extracellular matrix associated with the ILM and they promote RGC death via detachment-induced apoptosis (Zhang et al., 2004) . In the different sections that follow, we will refer to many other functions of astrocytes in more detail.
Microglial cells
Experimental evidence has confirmed the so called immune privilege of the CNS on the basis of the existence of the bloodebrain barrier (BBB), the absence of lymph or the lack of locally competent macrophages. However, more recent research supports the notion that the CNS establishes robust interactions with the immune system and that the microglia fulfils a key role in controlling immune responses (Carson et al., 2006) . The CNS reacts through immune responses that are both innate and adaptive, and that are mediated by distinct populations of immune competent cells. These cells may or may not share their embryonic origin but they communicate through direct contact and paracrine interactions. Microglia, astrocytes, infiltrating T-cells and macrophages form a complex and pleiotropic defence network that secures and protects the integrity of the CNS (Colton, 2009; Corraliza, 2014; Prinz and Priller, 2014; Ransohoff and Brown, 2012) .
Macrophages are a morphologically and functionally diverse group of cells as a consequence of their embryonic origin, cellular differentiation, tissue localization, and exposure to both internal or external stimuli (Gordon, 2003; Gordon and Martinez, 2010; Prinz and Priller, 2014) . The macrophage family includes meningeal and perivascular macrophages, blood circulating macrophages, dendritic cells derived from the bone marrow, and tissue resident macrophages (Wieghofer et al., 2014) . The microglia form a population of resident macrophages within the CNS that not only has immune activity but also, that participates in the development and maintenance of neural networks, as well as in tissue homeostasis (Fernandes et al., 2014; Gertig and Hanisch, 2014; Ransohoff and Brown, 2012) . Although the origin of these cells is controversial, it is believed that primitive myeloid progenitors of the egg sac are the precursors of these cells and not the bone marrow (Ginhoux et al., 2010; Schulz et al., 2012) , and during adulthood a population of local progenitors ensures the continuity of the microglia in the nervous system (Ajami et al., 2007) . Microglia have a quite specific morphology and physiology, very different from their precursors, and they adapt to their neural environment to fulfil their designated roles (Kettenmann et al., 2013) . As occurs with many advances in science (over time and through persistence), the morphological and functional definition of microglia has gradually been sculpted (Ginhoux et al., 2013) . The term "mesoglia" was proposed by Robertson (Ginhoux et al., 2013; Kettenmann et al., 2013) . Del Rio-Hortega in a conference delivered in 1938 at the University of Oxford (UK), defined microglia as the non-neuronal and non-astrocytic component of the "third element", of mesodermal origin, that can change its phenotype, migrate and proliferate. He also separated microglia from the oligodendroglia (Del Rio-Hortega, 1939) , a characterization that can still be applied today. Their plastic nature makes defining the functional phenotypes of microglia difficult. However, it seems clear that microglia can exist in different states of activation and "quiescence". Indeed, there seems to be a spectrum of intermediate states or functional phenotypes that may explain their complex physiology (Cherry et al., 2014) . For instance, when using artificial microstructured supports in vitro, these cells demonstrate a high degree of plasticity in distinct extracellular milieus (Amadio et al., 2013) .
Origin, morphology and distribution of microglia
Several cell pools of myeloid origin and with common molecular features populate the CNS, although they also exhibit important differences relating to their origin and activity. Experiments in mice confirmed that microglia originate in the yolk sac at an early stage of embryonic development, between 8.5 and 9.5 days postfertilisation (dpf) (Ginhoux et al., 2010; Schulz et al., 2012) . Specifically, they derive from erythromyeloid precursors . These stem cells undergo a sequential development from stage A1 when they express the CD45 antigen to stage A2, when they synthesize myeloid markers that include CX3CR1 (chemokine receptor 1) and CSF1R (colony-stimulating factor 1 receptor). Stage A2 cells migrate to the brain parenchyma with the aid of specific matrix metalloproteinases (MMPs), where they establish their final destination Prinz and Priller, 2014; Prinz et al., 2011) . By contrast, other macrophage populations that inhabit the CNS have different myeloid origins, which include the fetal liver, the aortaegonademesonephros region and the bone marrow Prinz and Priller, 2014) .
Microglia colonise CNS structures during embryogenesis and in the early postnatal period until they reach their positions in the mature brain (Harry, 2013) . Colonization occurs along different migratory pathways, following glial structures, white matter networks or blood vessels (Rezaie and Male, 1999) . In the CNS, microglia are distributed widely in the gray and white matter, and they present local singularities related to their function (Harry, 2013) . The diverse morphologies of the microglia are related to their activation states or functional phenotypes (Kettenmann et al., 2011) . Briefly, in the so called "resting" state they have a ramified appearance with a small cell body and rather large nucleus. In the "activated state" the cell morphology is more ameboid and they exhibit pseudopodia (Davis et al., 1994) . In healthy conditions microglia are found at variable densities in the different retinal layers, including the NFL, ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL) and OPL Cuenca et al., 2014; Garcia-Valenzuela et al., 2005; Noailles et al., 2014; Santiago et al., 2014; Sobrado-Calvo et al., 2007) . The cells have a small ovoid-shaped cell body and multiple ramifications in the GCL of the normal retina, and they are organized into a single sheet that is distributed homogeneously (Garcia-Valenzuela et al., 2005) . In the optic nerve, microglia ramifications appear to be orientated along the fibres. This orientation is disorganized in an experimental model of diabetes , and the distribution and organization of microglia within the retinal layers is altered in a variety of pathological states, when changes in cell shape can be observed Kezic et al., 2013) . Moreover, when RGCs are labelled with a retrograde vital fluorescent dye in an experimental axotomy, microglia containing RGC debris can be detected months after the injection of marker, indicating both the phagocytotic capacity of microglia and their relative longevity (Thanos et al., 1994) .
Plasticity and functional microglia phenotypes
Microglia fulfil specialized immune tasks, responding to specific stimuli by secreting cytokines and neurotrophic factors. In addition, they establish a close relationship with neurons and other cells so that they contribute to the remodelling of neuronal circuits, as well as to the elimination of cell debris and deranged synapses. Microglia also play a role in pathological events that affect the CNS (Kettenmann et al., 2013; Prinz et al., 2011; Wieghofer et al., 2014) . Microglia exist in two separate morphological/physiological states, namely "resting" and "activated" microglia (see for instance Colton, 2009; Kettenmann et al., 2011 Kettenmann et al., , 2013 Ransohoff and Perry, 2009) . In his early studies, Del Rio Hortega observed these two different morphologies and he related them to the primitive invasion of microglia (amoeboid) and the pool of settled cells in the mature brain (branched and ramified: (Del Rio-Hortega, 1939) . However, although these two states serve as a reference point, the adaptable and fine-tuned responses of microglia reinforce the existence of several intermediate and fully functional phenotypes (Cherry et al., 2014) . One basic response of microglia to local insults depends on the presence of extracellular ATP and it involves the specific extension of microglial processes to the injured site (Davalos et al., 2005) . This morphologicalephysiological tour has been called the "spider effect" (the spider in the middle of the web responds to vibration caused by the "intruder" and moves to the site where the prey is trapped, thereafter returning to its "vigilant" site in the middle of the web: (Jonas et al., 2012) . The concept of "resting" state implies an "inactive" condition and it may lead to confusion, since it suggests a passive behaviour that would only be converted to an "active", functional state under certain circumstances (for example, infection, malignancy, trauma, neurodegeneration, etc…). Experimental studies support the idea that even in healthy and homeostatic conditions, microglia are responsive to changes in the environment, and that they modulate numerous events by secreting cytokines and other factors, and by interacting with other glial cells and neurons (Kettenmann et al., 2011; Wieghofer et al., 2014) . Therefore, applying the term "surveying" instead of "resting" to vigilant microglia seems to be more appropriate (Santiago et al., 2014) (Fig. 6 ).
Representative molecular traits of microglia
Microglia produce many substances and they also have receptor systems that process chemical signals from neighbouring or distant cells. The complex physiology of microglia relies on their secretory capacity, and on the existence of multiple receptor systems for: neurotransmitters and neuromodulators (e.g., dopamine, GABA, glutamate, epinephrine/norepinephrine, cannabinoids, histamine, angiotensin II, opioids, bradykinin, neurotrophins, acetylcholine, etc…); cytokines and chemokines, including TNF-a (tumour necrosis factor) or interleukins; complement; epidermal growth factor (EGF); Notch; macrophage colony-stimulating factor; peptides; leukotrienes…etc. Microglia also express different transporter systems for solutes and ions (Kettenmann et al., 2011) .
Microglia communicate with other glial cells and neurons by secreting factors that establish specific secretory signatures characteristic of distinct functional or pathological states. The molecules secreted by microglia and other glial cells (both proteinaceous and non-proteinaceous) are defined as their secretome, and establishing its composition may be essential to discover biomarkers useful for diagnosis and prognosis, as well as in the search for new therapies to alleviate different CNS pathologies. Here we name just a few of the molecules that microglia are known to secrete, either constitutively or in response to inflammation, injury, CNS development and degeneration or homeostasis: cytokines and chemokines, ROS (reactive oxygen species), nitric oxide (NO), phospholipase A2 IIA type, BDNF (brain-derived neurotrophic factor), GDNF (glial cell line-derived neurotrophic factor), IGF (insulinlike growth factor), FGF-2 (fibroblast growth factor 2) or LC1 (lipocortin 1) (Jha et al., 2013) . Cell contacts and soluble factors are key elements to maintain the functional dialogue established between the different cell types that populate the retina and they are characteristic of a given activation state of microglia (Langmann, 2007) . A representative example of a neuronemicroglia interaction is the FKN/CX3CR1 system (fractalkine or CX3CL1 and its G proteincoupled receptor, CX3CR1). Fractalkine is a chemokine that may exist as a membrane-bound protein or in a soluble form, and it is present in neurons that bind to CX3CR1 expressed on microglia. The CX3CL1 ligand modulates the activation of microglia in distinct manners during homeostasis and in disease states (Sheridan and Murphy, 2013) . In the retina, the action of CX3CL1 depends on the conversion of the membrane-bound and soluble isoforms, and it participates in both neurogenesis and the response to cues that trigger neurodegeneration (Zieger et al., 2014) . Microglia also express adenosine receptors that regulate their activities both in healthy and disease states (Santiago et al., 2014) . Accordingly, microglial receptor proteins appear as important targets for the development of drugs to prevent or manage retinal neuroinflammation. The secretory capacity of microglia depends on nonvesicular (transporters or ion channels) and vesicular mechanisms, such as exocytosis and the release of extracellular membrane microvesicles (EMVs) loaded with bioactive molecules (Prada et al., 2013) .
Identification of microglia
Due to the important role of microglia, both in homeostasis and disease, it is of particular interest to develop tools to characterize and identify these cells, as well as the molecular dialogue they undertake in their multiple modulatory activities. This task is difficult, particularly since this group of cells share molecular identities with related cells of hematopoietic origin (Wieghofer et al., 2014) . The identification of cells is based on their localization and morphology, as well as on the specific expression of surface proteins and the functions associated to them. The methodological approaches may involve the use of specific antibodies to localize protein epitopes (immunocytochemistry, western blotting…) or the manipulation of gene expression. The identity of microglia can be assessed by using different protein markers (for instance, IBA-1, ED-1, HLA-DR, CD-45…etc). In most cases, the antibody markers (such as IBA-1 -ionized calcium binding adaptor molecule 1-and ED-1 -monoclonal antibody against glycoprotein CD68) can be used simultaneously to differentiate microglia from other cell-related populations, including migrating macrophages (Ellis-Behnke et al., 2013) . Since all types of macrophages and microglia express the F4/80 protein (a surface receptor of the EGF family), this marker alone is not suitable to target microglia. Histochemical detection also offers advantages in some cases. For instance, one histochemical method uses a tomato lectin with affinity for sugar moieties present on microglial and endothelial cells, allowing the relationship of microglia with blood vessels to be analysed (Villacampa et al., 2013) . Microglia in different activation states can be characterized using combinations of techniques aimed at analyzing the secretory, proteomic and transcriptional signatures (Glanzer et al., 2007) : microarrays, real-time RT-PCR (reverse transcription polymerase chain reaction), SELDI-TOF (surface-enhanced laser desorption ionization-time of flight), twodimensional gel electrophoresis (2D-PAGE), mass spectrometry, quantitative western blotting…etc.
Genetic manipulation serves to target microglia and has provided relevant tools to distinguish these cells from other myeloid cells. Different approaches are available and include labelling methods (where fluorescent reporter genes like GFP -green fluorescent protein-or LacZ -beta-galactosidase-may help to monitor the spatio-temporal expression of a given protein), as well as the manipulation (activation and deletion) of genes that produce stable transgenic animal lines (see Wieghofer et al., 2014 for a review). On occasions it is difficult to separate macrophage populations and to assign the specific involvement of each class to particular functions. In a knock-in mouse model, where CNS microglia were labelled with a GFP-tagged CX3CR1 and blood originated monocytes were labelled with a RFP (red fluorescent protein)-tagged CCR2, the genetic markers allowed "red" infiltrating monocytes and "green" resident macrophages to be visualized (Saederup et al., 2010) . This method has also been applied to localize microglial populations during development and at their final sites (Mizutani et al., 2012) . Based on the self-renewal capacity and the long lifespan of microglia, a genetic system has been developed where the expression of Cre recombinase (an enzyme that catalyzes sitespecific DNA recombination events) is controlled by the promoter of a gene that encodes Cx3cr1 . This experimental system allowed an in vivo animal model to be elaborated (Cx3cr1 Cre mouse) in which conditional depletion of a mitogen-associated protein kinase kinase kinase (MAPK3), TAK1
(transforming growth factor b-activated kinase 1), demonstrated the direct participation of microglia in autoimmune inflammation. This model opens new avenues to ascertain the role of different genes expressed in microglia at specific time points or under specific circumstances (physiological or pathological). Since many diverse techniques are available, it is important to be aware of the potential and the limitations of each of these when designing experiments to study the presence, morphology and function of microglia.
Common functions of different glial cells in the retina
The three glial cell subtypes present in the retina share many properties that while possibly redundant they have a preferential hierarchy in which they are performed. There are certain functions of retina glial cells that are more predominant in one cell type or another. Thus, in the following sections we will review the most recent advances related to this important issue and the role of these glial cells in maintaining retinal homeostasis.
Formation of boundaries
Müller cells share many properties with astrocytes, including the ability to ensheath axons, and to form glial boundaries between the retina and the blood vessels (Hollander et al., 1991) . However, while Müller cells are formed in the retina, astrocytes migrate independently of vessels and they are therefore in a position to respond to environmental signals in avascular areas of the retina. Their restriction to the inner layer of retina enables them to respond to hypoxia in this region by expressing VEGF, thereby inducing the formation of a superficial layer of blood vessels. By contrast, Müller cells extend across all retina layers and cannot respond in a layer-specific manner. The migration of astrocytes across the surface of the retina therefore provides a population of macroglial cells that is strategically located to sense hypoxia in the inner layers of retina.
In addition to the glia limitans of the retina and vessels, astrocytes and Müller cells both contribute to the glial sheaths around neurons. In particular, both astrocytes and Müller cells wrap ganglion cell axons into bundles, contributing to the glial convergence on the initial segments and node-like axon structures, and they also ensheath the somas of neurons in the RGC layer. Furthermore, adherens junctions form between astrocytes, between Müller cells, and between astrocytes and Müller cells, although not between these cells and neurons or among neurons. These similarities point to the possibility that astrocytes and Müller cells might act interchangeably in some processes, and we propose that they be regarded as variants of macroglia. Quantitative differences between astrocytes and Müller cells were noted in their ensheathment of neurons. Specifically, the glial sheaths around the somas of RGCs are predominantly formed by Müller cells (Fig. 3A,C) , while the glial processes attached to node-like specialisations of their axons are mainly formed by astrocytes ( Fig. 5A : Stone et al., 1995) . In dog retinas in particular we found that axons form packages that interdigitate between the endfeet of the Müller cells in way similar to the nests building (Fig. 2C) .
One qualitative difference has been that in two glial cell classes the gap junctions formed between astrocytes do not form between Müller cells or between these two different types of cells. Thus, the roles of the two types of glial cells, in terms of the information and communication related to the cells that are ensheathed could vary. Moreover, reactive astrocytes form a border between the lesion and the surrounding tissues, and as resting microglia are located in certain areas, close to where the retina is vascularised, they form an imaginary fence that limits the penetration of any invader into the retina.
Glia as a structural support for neurons
Viscoelastic properties
The biomechanical changes in the retina during its development and in disease are very important, and they could be the underlying cause of several conditions. During development and after the optic vesicle has closed, the intraocular pressure and proliferation of neuroblasts causes the primitive retina to stretch. After birth, the retina continues to expand tangentially, stretching out from the centre to periphery until the eye reaches a maximum size. During this growth period the components of the retina must be elastic. The retinal neurons are significantly stiffer than the glial cells, and elasticity decreases from the inner to the outer retina. Moreover, the two limiting membranes of the retina are stiffer that the rest of the layers. While the Müller cell endfeet, nerve fibre bundles and GC somata are stiff structures, the least elastic part of the retina is the ONL as well as the inner and outer photoreceptor segments (Franze et al., 2011; Lu et al., 2006) . The elastic stiffness of retinal Müller glial cells does not vary remarkably in the different mammalian species studied so far , and their viscoelastic properties appear to be similar in man, monkey and rat. In general, their elastic behaviour dominates over their viscous behaviour.
Müller cells act as mechanosensors, as they span vertically from the inner to the outer retina. The Müller cells form stiff endfeet that are rich in mechanosensitive ion channels, indicating that the biomechanical responsive element of the retina is located in this region. In addition to the different types of cells, the mechanical properties of soft tissues like the retina mainly depend on extracellular matrix components like collagen, elastin and proteoglycans. One of the main functions of proteoglycans is to retain water, which constitutes >70% of the retina. The presence of water in tissues causes collagen fibres to separate, swell and become disorganized, which significantly affects their relative stiffness and tensile strength (Chen et al., 2009a) .
The biomechanical scaffolding of the retina, as well as its biochemical homeostasis, is maintained by Müller cells and astrocytes. These cells can alter their elasticity and stiffness by up-and downregulating their IF proteins, the most common of which are GFAP and vimentin, thereby altering both the tissue-wide and cellular biomechanics of the retina (Bringmann et al., 2009a; Lindqvist et al., 2010; Lu et al., 2011) . In mice lacking GFAP and vimentin, mechanical challenge revealed an exaggerated fragility of Müller cells (Lundkvis et al., 2004) . Müller cells are mechanically heterogeneous in the lateral direction, although they seem to display a mechanical homogeneity in the vertical direction. Due to the distinct cytoskeletal organization in local regions of a Müller cell, the regions closer to the endfeet, soma and processes can be discerned by their mechanical properties (Lu et al., 2006) . This local variation in the mechanical compliance of a single Müller cell is likely to determine the mechanical diversity in the retina (Park and Lee, 2013) . Mechanosensory Ca 2þ ion channels, such as TRPV4, are known to be present on Müller cells, particularly on the Müller cell endfeet at the inner retinal border. Thus, these channels may also provide the retina with a sensor of biomechanical changes (Ryskamp et al., 2011) . In normal situations, in addition to morphological alterations due to glutamatergic neurotransmission, there are traction forces on Müller cells in the retina derived from the vitreous body. In the human retina, the vitreous body adheres to the retinal tissue at the peripheral retina through the major superficial retinal vessels, optic disc, perifovea and macula. At sites of vitreo-retinal attachments, the basement membrane of the ILM can become thinner, and vitreous fibres can adhere directly to Müller cells (Schubert, 1989) . However, there is limited information regarding the biomechanical properties of these cells (and of the retinal tissue). Experimental approaches are limited as it is unclear whether retinal cells and the tissue of laboratory animals suitably reflect human conditions .
Astrocytes are abundant in the CNS, and their role as passive nurturing cells has been broadened to a more dynamic function in terms of their relationship with other glial cells and neurons. Because of the specialized nature of astrocytes, their morphology and their location in the retina, one might envision that astrocytes in the retina may contain mechanical sensors. Accordingly, astrocytes might sense eye movements and other perturbations of the retina, for example an elevation of the intraocular pressure. Little is known about the indicators of the mechanical state, however it has been proposed that astrocytes at the optic nerve head could induce astrocytic signalling by releasing ATP (Barres and Dowling, 2010) . If this was to occur, ATP release could potentially stimulate microglial cells to migrate to the nerve head, activating astrocytes to become reactive and influence neurons or blood flow (Barres and Dowling, 2010) . Astrocytes respond to mechanical forces by triggering reactive gliosis, which might perturb their vasodilatory role by disrupting their vessel contacts and interfering with their gap junction coupling. Alternatively, this response could perturb the ionic homeostasis, since astrocytes are also vulnerable to neuronal death (Cahoy et al., 2008; Foo et al., 2011) .
Architecture-mechanical forces
The axons within the retina of all species are organized radially in order to converge at the optic nerve head, yet there are important differences in the way that astrocytes are distributed within the retina. While in the pig, minipig and human, astrocytes are organized in two levels one more vitreal and another more internal. The more vitreal astrocytes have a parallel disposition that can be observed in flat mount retinas (Fig. 5A ), while in rat and mice, the distribution of astrocytes is more stellate appearance and their extensions do not run parallel to the optic nerve (Figs. 4B and 5C). Astrocytes can modify their distribution in response to local changes and thus, after axotomy and explant culture the pattern of astrocytes observed in flat mount retinas is lost within a few days. It is possible that astrocytes sense the damage to the axons and thus, they tend to lose their contacts and redistribute within the retina. In mice and rats, astrocytes became hypertrophic and assume a stellate shape, as observed in glaucoma (Fig. 5) .
Müller cells also sense the changes that take place in the inner and outer retina (see below, "glaucoma and retinitis"). Müller cells modulate neuronal activity by regulating the concentration of neuroactive substances and potassium in the extracellular space through a variety of transport processes (Newman and Reichenbach, 1996) . This activity of Müller cells is particularly important in ischemia when there is a massive release of transmitters from neurons (Hossmann, 1993) . The plastic changes of the Müller cells take place over a relative short timescale (Fig. 7) . The three distinct layers of immunoreactivity originating from the extensions of the Müller cells, that are present in the IPL of control retinas, was no longer evident, rather, it appeared as a single thick layer after ischemia (Fig. 7F, H) .
The communication between Müller cells and RGCs remains unknown, although we did observe changes to Müller cells in retinas from animals with experimental glaucoma or axotomy (Hernandez et al., 2009 ).
Volume regulation
The regulation of cell volume is of great importance to avoid changes in neuronal excitability resulting from a decrease in the volume of the extracellular space. Cell swelling and subsequent Regulatory Volume Decrease (RVD) is accompanied by transmembrane potential (Vm) depolarization followed by repolarization. However, this RVD response depends closely on the composition of the extracellular media. Although K þ and Cl À channels play an important role in the RVD response of Müller cells, their contribution is evident only if a significant driving force for KCl efflux is present . The changes in volume of glial cells are also associated to the viscoelastic characteristics of the retina. It has been suggested that Müller cells possess endogenous cell volume-regulatory mechanisms that are involved in the activitydependent regulation of the volume of the extracellular space . In addition to Kir (inwardly rectifying potassium) channel mediated cell volume regulation, Müller cells possess receptor-mediated mechanisms that prevent hypoosmotic swelling (Uckermann et al., 2006; Wurm et al., 2008a) . Thus, pharmacological blockade of Kir channels causes swelling in brain astroglial somata and processes, yet it has no effect on Müller cells. The blockade of Kir channels in hypoosmotic conditions induces immediate swelling of Müller cell somata but no additional swelling in somata of brain astrocytes (Hirrlinger et al., 2008) . Water accumulation in retinal neurons and glial cells is a pathogenic factor involved in retinal degeneration under ischemichypoxic and inflammatory conditions. Nerve growth factor (NGF) prevents the osmotic swelling of Müller cells by inducing autocrine/paracrine FGF signalling, as well as indirectly controlling the swelling of bipolar cells by inducing a release of cytokines from Müller cells .
Müller cells of the rodent retina possess a volume-regulatory glutamatergicepurinergic signal transduction cascade. Glutamate induces the swelling of inner retinal neurons and shrinkage of the extracellular space. Retinal glial cells rapidly and significantly change their shape when glutamate is applied to retinal whole mounts, and this effect is induced by glutamate-evoked neuronal cell swelling (Uckermann et al., 2004; Wurm et al., 2008b) . Müller cells adapt their morphology to the increased size of activated retinal neurons by extending and thinning the inner stem process. This response is due to the opening of potassium and chloride channels, whereby the ion efflux compensates for the osmotic gradient across the Müller cell membrane and prevents cellular swelling (Uckermann et al., 2006) . The glial water channel aquaporin-4 (AQP4) is implicated in the control of ion and osmohomeostasis in the retina. The water flux through AQP4 is involved in the rapid volume regulation of retinal Müller cells in response to osmotic stress and deletion of AQP4 results in an inflammatory response of the retinal tissue (Pannicke et al., 2010) .
Müller cells can maintain the integrity of the blooderetina barrier and clear metabolic waste by regulating the homeostasis of extracellular pH and K þ ions. To avoid high K þ levels that might induce depolarization of retinal neurons, Müller cells take up excess K þ from the extracellular space (especially in the synaptic layers of the retina), and release it into the blood and vitreous humour Reichenbach et al., 2007) . Many of the homeostatic functions of Müller cells, including spatial potassium buffering and neurotransmitter uptake, depend on the negative membrane potential (around À80 mV) established by the ample expression of Kir4.1 in these cells, which can regulate and compensate the osmotic conditions Kofuji et al., 2000) . Kir 2.1 and Kir 4.1 channels were recently studied under hypoxic conditions, which produced no significant changes in their mRNA expression (Kang et al., 2013) . Adenosine might upregulate the expression of Kir 4.1 channels while it only weakly affects the expression of Kir 2.1 channels in vitro. Such upregulation of Kir 4.1 channels should accelerate retinal K þ clearance to prevent neuronal hyperexcitation and excessive release of glutamate . AQP4 are present in the plasma membranes of astrocytes that are in contact with micro vessels (Fig. 4B) , allowing them to regulate the extracellular space volume, waste clearance, potassium buffering, cell migration and calcium signalling (Nagelhus and Ottersen, 2013) , playing an important role in water homeostasis in the retina, moreover Müller cells play also a role in water regulation.
Metabolism
Glucose
The retina exhibits metabolic peculiarities that are related to its activity. Some specific characteristics of retinal oxidative and anabolic metabolism are also found in tissues that manifest high rates of proliferation (for instance, embryonic stem cells and tumour cells: Ng et al., 2014) . Glucose, obtained from external circulation, from internal cellular glycogen stores or from lactate is the primary metabolite used by retinal cells to produce energy, both in aerobic and anaerobic conditions .
Retinal cells also display specialised metabolic outcomes and they have adapted to better serve cell house-keeping needs and specific demands linked to processing visual inputs (phototransduction and neurotransmission). Within the retina, glial cells and neurons orchestrate complex metabolic relationships (providing nutrients and metabolites, responding to signals from neighbouring or distant cells, or adapting the transcriptional machinery to supply the required metabolites) that fine tune their metabolic activity to their needs. For example, Müller cells resist hypoxia and low glucose environments by activating anaerobic glycolysis and by oxidizing alternative substrates, such as lactate, glutamate or glutamine in order to obtain energy in the form of ATP (Kitano et al., 1996; Reichenbach and Bringmann, 2010; Stone et al., 1999; Winkler et al., 2000) . Compared with other tissues, the retina consumes more ATP (Hurley et al., 2014) and it undergoes an elevated proportion of aerobic glycolysis, the so-called Warburg effect (glucose is preferentially converted into lactate, instead of carbon dioxide and water by oxidative phosphorylation, despite the presence of oxygen). The Warburg effect favours rapid ATP production when glucose is converted into pyruvate and then fermented into lactate to regenerate oxidized NAD (nicotine adenine dinucleotide), and it may procure the energy needed for continuous rhodopsin production or for other processes (Casson et al., 2013; Ng et al., 2014) .
A few examples confirm that retinal cells configure a metabolic dialogue based on the expression and distribution of enzymes and metabolic carriers. Retinal cells also exhibit different energy metabolic profiles (for instance, glia, RGCs, photoreceptors) and a single cell may have different energy demands in different compartments (as is the case for RGCs) while still maintaining the internal homeostasis . Glucose and lactate are not the only primary metabolites catabolised to attend to the energy and vegetative requirements of the retina. Retinal pigment epithelium (RPE) cells metabolise fatty acids from phagocytised photoreceptor outer segment membranes by beoxidation. Also, RPE cells produce b-hydroxybutyrate from fatty acids (a ketone body) that is further incorporated into the TCA (tricarboxylic acid cycle) by retinal cells to obtain ATP, amino acids or other metabolites (due to the amphibolic properties of TCA). Müller and microglial cells also establish important metabolic relationships, both in functional and diseased retinas. In physiological conditions, Müller cells release ATP to the extracellular space that is used by microglia to fuel their motility (Wang and Wong, 2014) . Accordingly, an effective oxidative and biosynthetic dialogue is established between retinal cell components (Adijanto et al., 2014) .
Among the well-defined house-keeping activities of astrocytes, they provide neurons with essential metabolites (e.g., glucose), and they take up K þ and neurotransmitters from the extracellular space.
Although it was suggested that astrocytes can convert glycogen to glucose, it is not known under what conditions this occurs in vivo.
Although glucose production via the G6Pase complex in the endoplasmic reticulum is theoretically possible, other fates of G6P in the cell include lactate-energy production via glycolysis and entry into the pentose phosphate pathway. Also, there is controversial evidence that confers a glucose export capacity on astrocytes per se. The metabolic relationship between different retinal cell populations includes many molecules and reactions (Fig. 8) , and their detailed description is beyond the scope of this work. The reader is referred to some recent works that deal with this matter in more detail (Hosoya and Tachikawa, 2012; Hurley et al., 2014; Ng et al., 2014; Reichenbach and Bringmann, 2010; Sanderson et al., 2014; .
Lipid metabolism
Anabolic activities in photoreceptors are primarily directed toward the synthesis of outer segment discs, a highly membranous compartment of the photoreceptor and the site of the phototransduction cascade. The retina has the capacity to both synthesize cholesterol de novo and to take up lipids from the blood (Fliesler and Keller, 1997) . Circulating low-density lipoproteins (LDL) enter the retina via LDL receptors on RPE and Müller cells (Tserentsoodol et al., 2006) . There is a lipid shuttle from Müller cells to neurons to meet the need of neurons for lipids, especially to maintain the long RGC axons and the photoreceptor outer segments, as well as for synapse formation (Mauch et al., 2001) . Müller cells and astrocytes synthesize ApoE and ApoJ which are assembled into cholesterolrich lipoprotein particles that are thought to be secreted into the vitreous humour. From there the particles may be taken up by RGCs and transported centrally within the optic nerve. Although the exact mechanism involved in this uptake is still unclear (Amaratunga et al., 1996) , the implication of Müller glia in the intraretinal transport of lipids dependent on high density lipoprotein-like particles has been proposed (Tserentsoodol et al., 2006) . Docosahexaenoic acid (DHA) is a trophic factor required by photoreceptors for their disk membranes, and it drives several activities in the retina that can help protect photoreceptor cells from regular exposure to photooxidative damage. As a precursor for the neuroprotectin, NPD1, DHA helps to upregulate anti-apoptotic genes of the Bcl-2 family, while downregulating pro-apoptotic and pro-inflammatory genes (Bazan, 2007) . Müller cells take up DHA (Gordon and Bazan, 1990) , incorporate it into glial phospholipids and channel it towards the photoreceptors (Politi et al., 2001 ). Müller cells also express fatty acid-binding and -transfer proteins for the transport of DHA and other fatty acids (Deguchi et al., 1992; Kingma et al., 1998) . A potential mechanism for the antiinflammatory effects of DHA in diabetic retinopathy was recently suggested, whereby microglia recruit receptors into lipid rafts (Wang et al., 2015) .
Extracellular matrix generators
The extracellular matrix (ECM) provided by macroglia is an important source of supporting and signalling factors in the retina and it contributes to the ILM, which is the boundary between the retinal layers and the vitreous humour. ECM components are key mediators of glial activation, and they have the capacity to evoke both regenerative and degenerative effects on RGCs. The ECM produced by glia is altered during reactive gliosis, with many studies reporting a dramatic increase in the production of ECM components and the re-expression of extracellular glycoproteins that are down regulated after development. The following ECM components have been identified in the healthy adult mammalian retina, unless otherwise specified. 
Laminin
Laminins are a family of glycoproteins that are a major constituent of the ILM (Kohno et al., 1987) , and the specific laminin chains expressed in the retina are now starting to be elucidated. Laminin acts to anchor cells to the ECM but it also has important signalling functions transduced via transmembrane receptors like integrins and dystroglycan. In the adult human retina, laminin g1 has been detected at the ILM of retinal astrocytes, and laminins a4, b2 and g3 have been associated with Müller cells in the GC layer.
Other laminin chains present in the ILM that may be produced by retinal macroglia include laminins a1, a5 and b1. The specific heterotrimeric complexes of these laminins in the retinal ECM have not been fully determined (Libby et al., 2000) . RGCs express laminin chains a2 and b1 in the adult mouse retina, which suggests that they contribute to their own survival (Morissette and Carbonetto, 1995; Sarthy and Fu, 1990) .
Collagen
Collagen is another glycoprotein produced by glia and a constituent of the retinal ECM Collagen types I and IV was identified in the ILM of the human adult retina (Jerdan and Glaser, 1986) . Collagen type II was not found in the ILM but found in small "packages" in the vitreous humour, closely associating with Müller cell endfeet perhaps as a result of ECM remodelling (Ponsioen et al., 2005) . Furthermore, immortalised human Müller cells express collagens Types I-VII, IX and XI (Ponsioen et al., 2008) . Collagen-XVIII was also detected at the ILM of the adult human retina. Collagen XVIII is a basement membrane heparin sulphate proteoglycan (HSPG) that can be cleaved to form endostatin. Endostatin is a broad spectrum inhibitor of angiogenesis and it may interfere with the pro-angiogenic action of growth factors like basic FGF (bFGF/FGF-2) and VEGF. This suggests that the expression of Type XVIII collagen is related to retinal vascularisation in which astrocytes play an important role (Keenan et al., 2012) .
Vitronectin
Vitronectin, an extracellular glycoprotein that can bind to many components of the ECM and to integrins (specifically integrin avb5). Vitronectin is expressed in the RGC layer of adult human and mouse retinas, and it is up-regulated, along with its integrin receptor, following retinal damage (Anderson et al., 1999; Wang et al., 2006) . While vitronectin is expressed by RGCs, it is not expressed by astrocytes or Müller cells (Anderson et al., 1999) .
Fibronectin
Fibronectin is expressed by retinal astrocytes in neonatal rats and it plays an important role in angiogenesis (Jiang et al., 1994) . Fibronectin was also shown to be produced by cultured adult mouse retinal astrocytes (Scheef et al., 2005) , although there are inconsistent reports regarding fibronectin expression in the adult retina and it remains unclear whether or not it is found in the ILM of adult retina of different mammalian species (Chen et al., 2009b; Deeg et al., 2011; Hiscott et al., 1992; Kohno et al., 1987; Ljubimov et al., 1996) . Fibronectin has an important developmental role in vascularisation (Jiang et al., 1994 ), yet its function in the adult retina requires further study.
Tenascin
Tenascins are extracellular matrix glycoproteins with adhesive and counter-adhesive properties that can bind to a multitude of associated ECM proteins and cell surface receptors, including members of the integrin family (specifically a8b1 a9b1 avb3 and avb6: Morrison, 2006) . Tenascins can be cleaved by matrix metalloproteinases (MMPs) and serine proteinases, which alter their binding capacities. Astrocytes from the adult rat optic nerve that are unsupportive of RGC neurite outgrowth are reportedly tenascin negative (although Tenascin C -TN-C-was not assessed), whereas neonatal astrocytes that do support RGC outgrowth are found to express tenascin (Bahr et al., 1995) . A lack of tenascin expression has ben proposed to contribute to the failure of adult CNS regeneration (Bartsch et al., 1992) . More recently, TN-C upregulation was seen in optic nerve head astrocytes after experimental injury in rats (Johnson et al., 2007) and in glaucoma patients (Pena et al., 1999) . This suggests that tenascin is downregulated in cultured adult astrocytes that perhaps do not reflect events in vivo.
Interestingly, TN-C dampens the reactivity of cultured human astrocytes, transforming them to a quiescent phenotype, and glia appear to produce their own TN-C to modulate their own reactive phenotype in an autocrine manner (Holley et al., 2005) . Perhaps, the expression of TN-C during regeneration serves to maintain a manageable level of reactivity in order to promote a less inhibitory environment for RGC regeneration. TN-C expressed by astrocytes also acts at the retinal optic nerve junction, where it serves as a crucial molecular barrier preventing myelinating oligodendrocyte precursor cells (OPCs) from entering the retina (Bartsch et al., 1994; Morcos and Chan-Ling, 2000) .
Cultured Müller glia from P3 mice promote RGC axonal outgrowth and express the large TN-C isoform (Siddiqui et al., 2009) . Indeed, some isoforms of TN-C inhibit neurite extension whereas others vigorously promote neurite outgrowth, depending on their FnIII domains. The FNIII Domain D of TN-C is necessary to stimulate retinal outgrowth on Müller glia cells (Siddiqui et al., 2008 ). An increase in Müller cell proliferation has been observed on stiff substrates and an upregulation of connective tissue growth factor (CTGF) and TN-C on softer substrates (Davis et al., 2012) . Recently, Müller cells were shown to have the potential to re-enter the cell cycle and differentiate into multipotent neuronal progenitors that can regenerate cells in damaged areas. This can be induced in vitro by exposure to FGF2. TN-C is important in this process as it enhances Müller cell sensitivity to FGF2. Moreover, dedifferentiation was found to be impaired in TN-C knock-out mice (Besser et al., 2012) .
Proteoglycans
Chondroitin Sulphate Proteoglycans (CSPGs) are produced by retinal glia and have both positive and negative effects on RGCs. CSPGs are crucial mediators of axonal pathfinding during development, yet they are known to be inhibitory to axonal regeneration (Carulli et al., 2005) . The CSPG, neurocan, is upregulated by Müller cells in adult rat retina during reactive gliosis, suggesting that these cells may not support RGC regeneration (Inatani et al., 2000) . A comparative study of the ECM produced by different glial cells found that the ECM of Müller cells from neonatal mice express low levels of CSPGs and high levels of growth promoting molecules like laminin, fibronectin and TN-C. These Müller cells are a favourable substrate for RGC axon outgrowth and when the production of CSPGs is inhibited, axonal growth is enhanced. This suggests that the ECM of neonatal Müller cells contains more stimulating than inhibitory components and that it is a favourable substrate for RGC axons (Siddiqui et al., 2009) . These results highlight the need to further analyse the ECM produced by adult retinal glia in order to assess which growth promoting and growth inhibiting factors are altered with respect to neonatal cells.
Heparan Sulphate Proteoglycans The ILM of the adult human retina contains diverse heparan sulphate proteoglycans (HSPGs) including perlecan, agrin and Collagen Type XVIII (Clark et al., 2011; Keenan et al., 2012) . HSPGs are crucial for axonal guidance during retinal development (Chai and Morris, 1999) , although their role in the adult retina is not well understood. In mature tissue, sulphated proteoglycans are crucial for the correct function of many signal transduction pathways and for the binding of a multitude of molecules, including growth factors (e.g., VEGFs and FGFs), growth factor receptors, chemokines, matrix molecules, proteases and enzyme inhibitors. For this reason, it would be interesting to explore the roles of HSPGs in relation to mature RGCs since there may be multiple signalling pathways that are dependent upon this type of regulation.
Intermediate Filaments (IFs)
Following CNS injury, astrocytes and Müller cells upregulate the IF proteins GFAP, vimentin and nestin, which alters their physical properties and makes the cells more rigid. This allows them to establish a glial scar that is a physical and biochemical barrier to infection, as well as a barrier to regeneration. The upregulation of IFs also increases contact between cytoskeletal components and the ECM, enabling the cells to initiate rapid cytoskeletal alterations. Astrocytes and Müller cells have a polarised morphology (Enger et al., 2012) and the loss of this polarity may be one factor that contributes to their reactivity as they lose the crucial connection with the ECM.
In the retina, astrocytes and Müller cells express GFAP and vimentin at detectable levels in normal adult tissue and both are dramatically upregulated following damage to the retina (Lewis and Fisher, 2003) . It is unclear if GFAP is expressed by unreactive Müller cells since while there are reports that it is only expressed at times of stress (Kim et al., 1998; Xu et al., 2009 ) it has also been detected in Müller cell processes of healthy retinas (Erickson et al., 1987) . Increased expression of GFAP and vimentin increases the stiffness of the cells, which does not encourage axonal regeneration because growing neurites prefer soft substrates . There is also evidence that retinal astrocytes in zebrafish express GFAP weakly and rather, they rely on cytokeratin IFs to maintain their structural stability, which perhaps produces a less rigid scar than in mammals (Koke et al., 2010) . There may also be alterations to intrinsic cell receptors in adult RGCs that make them unresponsive to extracellular guidance cues since they are less capable of extending processes through 3-dimensional cultures of astrocytes than embryonic RGCs, suggesting that their cellecell adhesion properties are significantly altered (Fawcett et al., 1989) .
Nestin is expressed very weakly in healthy tissues but it is upregulated after retinal damage, for example in induced glaucoma (Xue et al., 2006a) , optic nerve transection (Xue et al., 2006b) or after laser injury (Kohno et al., 2006) . Nestin was recently shown to be upregulated in a subpopulation of Müller/astrocytes in the RGC layer in a rat model of Retinitis pigmentosa. Nestin is better known as a stem cell marker and it is associated with proliferating cells, such as stem cells and progenitor cells, and it was proposed that the re-expression of nestin signifies the dedifferentiation of Müller cells (Valamanesh et al., 2013) . The upregulation of nestin by Müller cells and astrocytes has also been reported following experimental retinal detachment in the adult rat and where differential expression of nestin within the Müller cell population was observed (Luna et al., 2010) . Synemin is another IF protein that is upregulated in both Müller glia and astrocytes and like nestin, it is similarly downregulated after development and its re-expression in Müller cells following injury may be an indicator of de-differentiation (Luna et al., 2010) .
In summary, the ECM substrate provided by confluent Müller cells in vitro favours the growth and regeneration of RGCs . Moreover, the best conditions for RGCs involve a combination of ECM plus secreted factors from Müller cells (Vecino et al., 2015b) .
N-Cadherin
N-Cadherin is essential for neurite outgrowth, as evident when embryonic chick RGCs are cultured on rat cortical astrocytes (Neugebauer et al., 1988) . Similarly, N-Cadherin is required for neurite outgrowth when in contact with Müller cells in vitro and in vivo (Riehl et al., 1996) . Retinal axons from embryonic mouse explants express N-cadherin when cultured on astrocytes whilst those from adult explants do not. N-Cadherin fulfils crucial developmental functions in the embryonic retina and it is downregulated in the adult retina (Bates et al., 1999) . However, N-Cadherin is upregulated during regeneration in the adult zebrafish retina (Liu et al., 2002) . Thus, the inability of the mammalian retina to re-express N-Cadherin following injury may be one of the reasons that RGCs don't regenerate, making N-Cadherin a potential therapeutic target.
Integrins
Integrins are membrane-spanning adhesion molecules that link the intracellular cytoskeleton to the ECM. Integrins are composed of a and b subunits, of which there are multiple types, and the resulting heterodimers allow cells to respond to adhesion through a number of different ECM ligands. Integrin-mediated cell-adhesion allows cells to communicate with their environment and the surrounding ECM, favouring alterations to the extracellular milieu to be relayed back to the cell, which then alters its morphology accordingly. Loss of the connection between the cell and the ECM, for example by MMP induced proteolysis, is one way in which retinal degeneration can progress. Based on current evidence, integrin signalling in RGC-glia interactions is crucial for cell survival, process extension and the maintenance of correct retinal function, although the promiscuity of integrin subunit heterodimers combined with their temporal expression in the retina make it difficult to draw definitive conclusions regarding the functions of specific integrins. What is clear is that throughout retinal development and during degeneration there is a strong requirement for b1 integrin signalling to promote cell survival and outgrowth. The importance of b1 class integrins in mediating RGC neurite outgrowth in the developing retina has been well characterised in the chick and mouse embryonic retina and the a-subunits were found to be expressed in RGCs (Bosco et al., 1994; Bossy et al., 1991; Bradshaw et al., 1995; Cann et al., 1996; Cohen et al., 1987; de Curtis, 1993; Duband et al., 1992; Hall et al., 1987; Sheppard et al., 1994) .
Adult rat RGCs preserve the capacity to survive and regenerate in the presence of different ECM components, such as laminin, fibronectin, collagen I and collagen IV, demonstrating the tremendous plasticity of adult RGCs to reprogram their ability to express different integrins depending of the substratum in which they grow (Vecino et al., 2015b) . It is clear that RGCs are in contact with different ECM components produced by different glial cells within the retina. As the axons exit the optic nerve they come into contact with the ECM components of the optic nerve head, lamina cribosa, optic nerve axons and oligodendrocytes. Thus, RGCs must express different sets of integrins in order to survive when in contact with different substrata and glial cell types, preserving their capacity to regenerate. We have described the beneficial effect of Müller cells on the survival and the capacity of RGCs to regenerate neurites (Fig. 9) . Müller cells secrete beneficial factors but they are even more beneficial when RGCs are grown on a confluent Müller cell substratum Higginson et al., 2013) . The beneficial effects of Müller cells therefore appear to be due to secreted factors and adhesion molecules present on these cells.
Adult human Müller cells express a1, a2, a3 and b1 integrin subunits in culture (Guidry et al., 2003) and cultured rat Müller cells from P3 rats strongly express the b1 integrin subunit (Siddiqui et al., 2009) . Multiple integrin heterodimers are expressed in astrocytes and the expression of a2, a3, a6, b1 and b4 integrin subunits by astrocytes of the adult human optic nerve head has been reported (Morrison, 2006) . Thus, based on the resultant heterodimers, we can predict that laminin and collagen are important ECM components in this structure. In terms of RGC-astrocyte interactions, whilst there could be bi-directional integrin communication in both cells, the primary role of astrocytes in this context is likely to be the provision of binding partners for the integrin subunits expressed by RGCs in order to relay survival signals.
Regulation of neuronal activity
Glial cells are classically viewed as passive participants in synaptic function. However, there is much evidence that there is a dynamic two-way communication between glia and neurons at the synapse (Barres, 1991) . Neurotransmitters released from presynaptic neurons evoke increases in Ca 2þ in adjacent glia. Activated glia then release transmitters, including glutamate and ATP, and these glio-transmitters feedback onto the pre-synaptic terminal to either enhance or supress further neurotransmitter release. Transmitters released from glia can also directly stimulate postsynaptic neurons, producing either excitatory or inhibitory responses. Müller cells envelop synapses in the retina, like Bergmann glia in the cerebellum or Schwann cells at the pre-synaptic neuromuscular junction. Thus, the precise shaping of synaptic activity depends upon the kinetics of both the pre-synaptic neurotransmitter release and transmitter re-uptake. In the retina, photoreceptor cells, neurons and macroglial cells express highaffinity transporters for neurotransmitters, all contributing to synaptic function in the retina. As previously indicated in this review the role of microglia is mainly related to their macrophage action during damage and to their capacity of secreting chemical signals that contribute to inflammation, cell death and cell survival. However, microglia also have essential activities that control synaptic connections and synaptic activity in the healthy brain, both during development and in adulthood (Schafer et al., 2013) . Microglia contact synaptic elements, dendritic spines and peri-synaptic astrocytes, through processes that extend and retract dynamically (Tremblay et al., 2010) . The release of microglial factors influences both neurotransmission and synaptic plasticity (Bilimoria and Stevens, 2014; Schafer et al., 2013) . Microglia modify the number of synapses in different circumstances and they directly eliminate specific synaptic contacts or those in close collaboration with astrocytes (Miyamoto et al., 2013) . One key candidate that seems to play an important role in synapse elimination/remodelling is the classical complement cascade (Mastellos, 2014; Stephan et al., 2012; Stevens et al., 2007) . For instance, the remodelling of synapses during the development of the visual system depends on the integrity of the complement cascade, given that genetic deletion of important components of this protein family block the capacity of microglia to properly remove specific synapses (Schafer et al., 2012) . Indeed, astrocytes induce the expression of complement elements in the CNS and they act in conjunction with microglia that eliminate complement tagged synapses during synapse pruning (Stephan et al., 2012) . Astrocytes also engulf and eliminate synapses through a mechanism independent of complement activation, both during development and in adults (Chung et al., 2013) . Other molecular mechanisms that trigger the phagocytotic intervention of microglia involve the major histocompatibility complex (MHC class 1), glutamate receptors and ATP signalling, etc (Miyamoto et al., 2013) .
Gamma-Aminobutyric acid (GABA)
In addition to GABA and Glutamate, Müller cells express, take up and exchange various neurotransmitters . In the outer retina, Müller cells are responsible for all GABA removal, whereas they share that task with amacrine cells in the inner retina (Marc, 1992) . Astrocytes express a wide variety of neurotransmitter receptors (Porter and McCarthy, 1997) and glia responses to neurotransmitters were initially characterized using cultured astrocytes as a model system. The release of several different neurotransmitters from active neurons can stimulate glia in intact tissue preparations, evoking increases in glia calcium. These responses are mediated by several glutamate receptors, GABA B receptors and muscarinic ACh receptors (Kang et al., 1998; Pasti et al., 1997) . Moreover, the capacity of glia to respond to neuronal activity suggests that they might regulate local blood flow in response to changes in neuronal activity (Paulson and Newman, 1987) , which would be crucial for retinal damage.
Transmitter release from neurons can stimulate glia and provoke the release of glutamate, ATP and other neuroactive substances from glia. These gliotransmitters that are released by glia can directly stimulate post-synaptic neurons, evoking either excitatory or inhibitory responses in these cells (Newman, 2003) . However, whether such responses also take place in vivo remains unclear. Another interesting question that must be addressed is if the heterogeneity of glial cells and their actions influence the survival of different neurons, or if different neurons are responsible for modulating resistance to damage.
Glutamate
Glutamate is the main excitatory neurotransmitter in the retina, which is used in the transmission of visual signals by photoreceptors, bipolar and ganglion cells. In the outer retina, glutamate is continuously released by photoreceptor terminals in the dark and this release is inhibited by light. In the IPL, ON-bipolar cells release glutamate during light exposure whereas OFF-bipolar cells release glutamate in the dark . Müller cells are the main elements responsible for the removal of excess glutamate released by the RGCs. The Müller cells are interposed between the vessels and RGCs, creating a barrier through which the Müller cells provide nutrients and release essential substances to the RGCs (Bringmann et al., 2009b) . The major glutamate uptake carrier of Müller cells is the electrogenic glutamate-aspartate transporter (GLAST, excitatory amino acid transporter-1, EAAT1: Derouiche and Rauen, 1995) .
After EAAT-mediated glutamate uptake into Müller cells, glutamate is converted to glutamine by glutamine synthetase (GS), and subsequently, glutamine is transported back to the neurons for glutamate re-synthesis (Danbolt, 2001 ). Glucose deprivation results in an increased glutamate uptake as well as the upregulation of EAAT1 and EAAT2 expression, indicative of a regulatory mechanism that prevents excitotoxicity in neighbouring RGCs. Indeed, glutamate uptake by Müller cells would appear to be essential to RGC survival (Toft-Kehler et al., 2014 (Bruckner et al., 2012) .
ATP and adenosine
Glutamate and ATP are candidates for neuron-to-glia signalling associated with volume (Uckermann et al., 2006) . Indeed, 'pathological' osmotic swelling of retinal (Müller) glia in rat retinal slices (evoked by the potassium channel blocker, barium chloride, by inflammatory lipid mediators, or under pathological conditions like diabetes and ischemia) can be prevented by pharmacological activation of purinergic P2Y and adenosine receptors (Uckermann et al., 2006; Wurm et al., 2008a) . Activation of purinergic receptors was recently concluded to be fundamentally involved in the regulation of glial cell volume and thus, in the homeostasis of the of the extracellular space mediated by these cells . Moreover, the inhibitory effects of VEGF and glutamate on the swelling of mouse Müller cells is mediated by transactivation of P2Y1R, as well as by intracellular calcium signalling through IP3R2 activation .
Adenosine is a reactive metabolite involved in cellular communication in some pathological states and in the eye, retinal ischemia and/or hypoxia provokes an increase of adenosine. Four adenosine receptor subtypes have been identified (A1, A2A, A2B and A3: Kang et al., 2013) . In the retina, adenosine suppresses excitatory neurotransmission through various mechanisms, including the inhibition of pre-synaptic voltage-dependent calcium channels (Housley et al., 2009 ). Since adenosine is a downstream mediator of the swelling-inhibitory actions of glutamate and ATP, it is likely that the inhibitory effect of adenosine induces chloride channel opening (Bruckner et al., 2012) .
Synaptic pruning
Synaptic pruning refers to the sculpting that reduces and remodels excess synaptic neuronal contacts to obtain functional neuronal circuits, a process that takes place mainly during development but that also occurs in the mature brain. Astrocytes and microglia fulfil a key function in synaptic pruning through different mechanisms that ultimately combine to conform a robust neural network. Microglia employ their phagocytotic and secretory activities to control the neural circuits in healthy brains (Bilimoria and Stevens, 2014) In mouse, for example, microglia engulf synapses during synaptic maturation given that proteins like PSD95 (a marker of excitatory postsynaptic density) and SNAP25 (a presynaptically localized protein) can be found inside microglial cells (Paolicelli et al., 2011) . Synaptic pruning is delayed in mice with microglia lacking the chemokine receptor Cx3cr1, indicating that their neuronal networks were immature (Paolicelli et al., 2011) .
Astrocytes in both the adult and developing brain mediate the elimination of synapses and therefore, they participate in the reshaping of neural circuits. Astrocytes participate in the formation of functional synapses within the CNS and they can control synapse maintenance in vitro (Ullian et al., 2001 ). Glypican (HSPGs) 4 (Gpc4) and 6 (Gpc6) are secreted by astrocytes, and they induce functional synapses between purified RGCs (Allen et al., 2012) Indeed, the application of Gpc4 to neurons increases glutamatergic neurotransmission. Astrocytes can also eliminate synapses through two phagocytotic receptors, namely Megf10 and Mertk, and their capacity to engulf synapses depends on neuronal activity (Chung et al., 2013) .
The complement system is part of humoural immunity, involving a group of proteins that participate in the elimination of alien cells and debris. However, new functions of this tagging system are observed in relation to neuronal differentiation and the establishment of neuronal networks in the CNS (Mastellos, 2014) . Synaptic components tagged with proteins of the complement system are eliminated by microglia and astrocytes, and they collaborate in this process by secreting signals that induce the synthesis of complement proteins by neurons (Stephan et al., 2012) . Selective elimination of synapses during post-natal development requires the expression of C1q in cultured RGCs, the initiating protein in the complement cascade (Stevens, 2008; Stevens et al., 2007) . Moreover, the absence of the C1q or C3 protein in mice (downstream elements in the complement cascade) leads to excessive retinal innervation of the LGN (lateral geniculate nucleus) as a consequence of defective synapse pruning, and neural activity regulates the engulfing capacity of microglia (Schafer et al., 2012) . Other phagocytotic mechanisms may be implicated in the process of synaptic pruning and thus, further studies in other regions of the CNS and in different experimental models will be needed to ascertain the precise role of microglia and astrocytes in the remodelling of synapses during development and in maturity. Indeed, many questions are still unanswered and the role of glial cells in CNS remodelling remains ill-defined (Schafer et al., 2013) .
A close relationship exists between Müller cells and RGCs, whereby glial cell processes often ensheath ganglion cell somata, as well as some of the axonal, dendritic and synaptic regions of these retinal neurons, an ensheathing pattern also common to astrocytic processes (Hollander et al., 1991) . This intimate association between glia and neurons is thought to allow glial cells to promote synapse formation and it helps maintain neuronal function by providing nerve terminals with energy substrates and neurotransmitter precursors (Pfrieger and Barres, 1996) .
Immune responses
The retina is considered an immune-privileged tissue and therefore, a multitude of mechanisms operate in the eye to limit the harmful inflammation that foreign substances provoke. At the same time, different mechanisms defend the eye from invading pathogens, with ocular cell surface and soluble factors maintaining the eye's immunosuppressive nature. RGCs are thought to play a major role in the recognition and subsequent clearance of pathogens during infection, and they are believed to represent the first line of defence in the retina. While microglial cells are mainly responsible for these effects, astrocytes and Müller cells also collaborate in this activity. Microglial cells are capable of modifying their positions in order to maintain homeostasis, however, both astrocytes and Müller cells can detect damage since both expand their projections to the blood vessels while essentially maintaining their positions.
Different immune cells are situated at different locations within the retina. Dendritic cells (MHC-II þ 33D1 þ ) are preferentially located around the optic disc and the peripheral margin of the retina . Moreover, their role in optic nerve and retinal inflammation remains to be elucidated. Perivascular macrophages play a critical role in retinal vascular inflammation and they may also participate in neuronal retinal defence. Microglial cells are the main innate immune cells in the retina and their activation is tightly regulated by a number of inhibitory pathways, including CD200/CD200R (Copland et al., 2010) or CX3CL1/CX3CR1 . Complement proteins are expressed in the retina under normal physiological conditions (Luo et al., 2011) and their expression augments in pathological conditions like inflammation (Chen et al., 2010) and ageing (Chen et al., 2007) . Complement activation is related to various retinal inflammatory and degenerative diseases, and modulating these pathways may have therapeutic applications. Recent studies have shown that Müller glia actively participate in retinal innate immunity, specifically in infectious conditions like bacterial endophthalmitis, an activity that involves their Toll-like receptors, phagocytosis, and the secretion of cytokines and chemokines. Müller cells also influence the adaptive arm of immunity by inhibiting the proliferation of T-cells via membrane-bound molecules. As a consequence of Müller cell activation, proinflammatory cytokines and other potent mediators of inflammation are synthesised and released (Kumar et al., 2013) .
Müller glia cells increase complement protein expression (Kuehn et al., 2006) . The complement protein C1q, an initiator of the classical complement cascade, is upregulated in neurodegenerative diseases like Alzheimer's and amyotrophic lateral sclerosis (ALS), as well as in rodent and human glaucoma (Stasi et al., 2006; Stevens et al., 2007) . The complement cascade has been implicated in the normal elimination of synapses by RGCs during visual system development in the DBA/2J mouse model of glaucoma . Thus, it might be possible that complement protein deposition occurs prior to significant loss of RGCs in the IPL. These findings strongly suggest that a normal mechanism of developmental synapse elimination is reactivated in the mature visual system by the glaucomatous process, and that this process of synapse elimination may well entirely drive glaucomatous neurodegeneration. Most of the secreted C1q is released by microglia, which express C1q mRNA strongly. However, what communication occurs between astrocytes and microglia, and the chronology of the events that take place in the early stages of glaucoma remain unclear, although it is known that microglial activation is an early event in this process (Bosco et al., 2008; Steele et al., 2006) .
Müller cells produce different cytokines in response to different stimuli. For example, IL-1b (interleukin-1b) and TNF-a are potent inducers of IL-8 expression in Müller cells (Liu et al., 2014b) , and IL1b and lipopolysaccharide (LPS) also provoke IL-6 production (Yoshida et al., 2001 ). IL-6 is a key cytokine in the host's defence against environmental stress, such as infection, inflammation and injury (Mesquida et al., 2014) . Indeed, the dysregulated and persistent production of IL-6 has been implicated in the development of various autoimmune and chronic inflammatory diseases, as well as ocular disorders. These cytokines can stimulate fibroblasts, endothelial cells and macrophages to produce chemokines, promoting the recruitment of neutrophils and macrophages to the retina, thereby resulting in further tissue damage and chronic inflammation. It is now known how IL-6 expression is regulated in Müller cells. These cells produce high levels of IL-6 in response to IL-1b stimulation and activation of the p38MAPK/NF-kB signalling pathway plays a predominant role in regulating IL-6 expression (Liu et al., 2014c) .
Some activities are common to the immune system and CNS: the secretion of immunoregulatory cytokines; the response to cytokines; and antigen presentation. These properties reflect the physical contact between the two systems (microglia, astrocytes and Müller cells presenting antigen to T cells) and their communication via soluble factors like cytokines. Indeed, cytokines mediate a complex circuit of interactions, especially in the event of lymphoid-mononuclear cell infiltration into the retina. The secre- and ultimate downregulation of immune responses and cytokine production within the retina depends on: a dynamic interaction between a variety of peripheral immune cells and retinal cells; the activation of these cells; the presence of cytokines with pleiotropic effects; the concentration and location of these cytokines in the retina; and the temporal sequence in which a particular cell responds to these cytokines. Thus, the ultimate outcome of immunological and inflammatory events in the retina will be determined in part by the interplay of these parameters (Benveniste, 1993) .
Gliosis
In the retina, reactive gliosis alters the morphology of the retina through hypertrophy, Müller cells and astrocytes provoking the thickening and enlargement of processes. This response occurs in a multitude of disorders like trauma, ischemic damage, infection, neuroinflammation or neurodegeneration, and in addition to the morphological changes, dramatic alterations in astrocyte gene expression occurs (Hernandez et al., 2000; Pekny and Nilsson, 2005) . The concept of reactive astrogliosis, especially its molecular and cellular characteristics, are still ill-defined, and we are only starting to understand its multifaceted contribution to disease pathogenesis and recovery from injuries (Barres, 2008; Burda and Sofroniew, 2014; Zamanian et al., 2012) . In reactive gliosis the expression of many genes is altered, and these cells exhibit distinct morphological and functional features. Given the molecular complexity of the response of reactive astrocytes, it is unlikely that a single molecular target or pathway will be implicated, indicating that gliosis is a very complex reaction in which many elements are implicated .
In response to infection and in certain inflammatory scenarios, Müller cells undergo reactive gliosis. Müller gliosis is a generalized, more unspecific, yet a very complex response of Müller glia towards injury or infection. Müller cells become activated by nearly every pathological challenge in the retina (Bringmann et al., 2009a) .
Reactive gliosis is thought to be the result of signals received from the injured or diseased tissue that sets off a molecular cascade within the glial cells to provoke a change of state (Fischer and Bongini, 2010) . Typical features of Müller cell gliosis involve cellular hypertrophy, up-regulation of IF expression (e.g., GFAP and vimentin), increased rates of proliferation, loss of function, inflammation, downregulation of GS expression, and tissue and vasculature remodelling (Belecky-Adams et al., 2013) .
A mild to severe continuum of the states of reactive gliosis may exist. In the mild to moderate forms of gliosis, the cells may undergo hypertrophy and show some changes to their functionality, yet if the trigger is removed, the cells might revert back to their former condition without altering the tissue. In the more severe forms of reactive gliosis, cells undergo hypertrophy, lose their functionality, form glial scars that are inhibitory to axonal regeneration and neuronal survival, and they may also proliferate The more severe state is marked by the persistence of these characteristics. Proliferative gliosis is generally associated with chronic gliosis and it is usually detrimental but it can also have a beneficial effect (Sofroniew, 2009 ). In such a state, the integrity of the blooderetina barrier is lost and as a result, serum components leak into the perivascular space, causing the re-entry of Müller cells into the cell cycle and their proliferation (Bringmann et al., 2009a; Coorey et al., 2012) .
The release of VEGF by Müller cells under conditions stimulating gliosis is especially interesting, as it acts in two directions. VEGF is neuroprotective at low concentrations but at high concentrations it causes all sorts of vascular pathologies. VEGF has neurotrophic effects and can prolong the survival time of cells by inducing angiogenesis, which in turn attenuates brain edema after cerebral ischemia/reperfusion and neuron injury. The neuroprotective effect of VEGF was proposed to be unrelated to its angiogenic effect but more closely related with its direct stimulation of neuronal and endothelial activity (Oosthuyse et al., 2001 ). The regeneration of neurons together with angiogenesis could be improved by VEGF, especially after ischemia (Ma et al., 2011) . Conversely, the excessive and prolonged expression of VEGF has devastating effects on the retinal vasculature and/or Müller cell proliferation, which in turn might lead to retinal neurodegeneration (Tolentino et al., 2002) . Moreover, calcium contributes to the high-glucose-induced expression of the angiogenic factors HIF-1a and VEGF by retinal Müller cells. The activation of the CaMKII-CREB pathway by high-glucose may be a possible mechanism underlying the pathogenesis of diabetic retinopathy (Li et al., 2012) .
Müller cells are not alone in influencing the effects of VEGF as astrocytes are also considered a target for ischemic damage. Apart from their neuroprotective effect on neurons and their detoxification of various ROS at the acute stage of ischemic stroke, reactive astrocytes profoundly affect later post-ischemic stages. This influence may be mediated by the secretion of VEGF, which stimulates the formation of new blood vessels and synaptogenesis, or by the secretion of synaptogenic thrombospondin (Christopherson et al., 2005) . The positive stimulatory effect of VEGF on vessel and synapse formation in ischemic stroke, contrasts with its induction of blood-retinal barrier breakdown and lymphocyte infiltration in autoimmune CNS inflammation (Argaw et al., 2009) . It is also noteworthy that treatment with GDNF enhances neuronal survival in ischemic brain tissue and that GDNF is up regulated in reactive astrocytes in the peri-infarct region (Kokaia et al., 1999) . Netrin-4, is a positive regulator of retinal angiogenesis and Müller cells generate Netrin-4 in a hypoxia-and VEGF-dependent manner, another example of a multifunctional protein produced by Müller cells that may influence their complex relationship with retinal neurons. Netrin-4 can support both axon guidance and angiogenesis in early development, as well as modifying regenerative neurite growth and neovascularisation (NV) under pathological conditions (Lange et al., 2012) .
Surfactant protein A (SP-A) upregulates cytokine expression in lung disease associated to prematurity. SP-A expression and localization has now been characterized in the mouse retina, as has its impact on NV in the mouse. Retinal and Müller cell SP-A is upregulated via the NFkB pathway and it is up regulated during the hypoxia phase of oxygen-induced retinopathy (OIR). A lack of SP-A attenuates NV in the OIR model and thus, SP-A may be a marker of retinal inflammation during NV (Bhatti et al., 2014) . Müller cells also produce PEDF (Pigment epithelium-derived factor), TGF-b and thrombospondin-1 as anti-angiogenic proteins that are important in adjusting the ''angiogenic balance'' (Eichler et al., 2004) . Recent studies suggest that in addition to PEDF (Yafai et al., 2007) , TGF-b2 is one of the Müller cell derived factors that limit intra-retinal NV .
Within the mammalian retina, both the Müller glia and retinal astrocytes react to injury and disease. Although the mechanisms and triggers involved have not been fully characterized. A variety of growth factor signalling mechanisms have been found to be important in reactive gliosis, such as those of EGF, FGF, TNF-a, ciliary neurotrophic factor (CNTF), insulin and WNTs (Nakazawa et al., 2006; Sofroniew, 2009) . Bone morphogenetic protein 7 (BMP7) also induces changes in the mRNA and protein of markers typically associated with reactive gliosis in retinal astrocytes and Müller glial cells, including GFAP, GS, a subset of CSPGs, MMPs, and other molecules .
Neuroprotection
Neurotrophic factors
Neurotrophins and growth factors are involved in the survival, differentiation and development of neurons. Administration of different combinations of neurotrophins in the eye has been reported to increase RGC survival in different experimental paradigms. Glial cells are important to maintain the survival of neurons, although the factors involved in the development and survival of glial cells themselves are less well defined. Glial like Müller cells, astrocytes and microglia are known to synthesise neurotrophic factors and these can directly or indirectly mediate neurotrophic actions Ruiz-Ederra et al., 2003; Vecino et al., 1998a Vecino et al., , 1998b . In order to define the cell-to-cell communication between Müller glia and neurons, it is essential to first isolate the respective cell types. When adult retinas were maintained in vitro for 6 days, the expression of neurotrophins and their receptors was preserved in glial cells and in RGCs, irrespective of the substrate on which they were cultured ( Fig. 10 : Garcia et al., 2002) . Moreover, the factors secreted by Müller cells offered protection to RGCs .
The distribution of neurotrophins and their receptors in the mammalian retina has been studied in detail, even in pathological conditions like ischemia or following NMDA induced exitotoxicity (Vecino et al., 1998b (Vecino et al., , 1999 . BDNF expression by rat RGCs is completely blocked after intravitreal injection of NMDA, as is choline acetyltransferase (ChAT) immunoreactivity associated with a subset of amacrine cells. However, immediately after NMDA injection, BDNF mRNA expression by RGCs and its immunoreactivity is enhanced, while the amacrine cell ChAT immunoreactivity is clearly reduced, and expression of the mRNA transcripts encoding rhodopsin and Thy-1 does not change. However, a few hours later an increase in BDNF expression is no longer apparent, suggesting that the synthesis of BDNF increases in RGCs immediately after an NMDA insult a natural protective mechanism in retinal cells (Vecino et al., 1999) . A similar transitory increase of BDNF and its high-affinity TrkB receptor is also found in photoreceptors and RGCs after ischemia-reperfusion. The mechanisms underlying BDNF induced neuroprotection are unknown, although it has been suggested that the BDNF derived upregulation of GLAST and GS may contribute to this effect. Indeed, BDNF has a protective effect on GLAST and GS expression by Müller cells under hypoxic conditions, which could induce neuroprotection (Dai et al., 2012b) .
The Müller cell extensions that form three laminae in the IPL of the rat retina contain p75. After ischemia, there is a progressive disorganization of the laminae that is worse after 24hr than after 2hr of reperfusion (Fig. 7) . Müller cells modulate neuronal activity by regulating the concentration of neuroactive substances and potassium in the extracellular space by means of a variety of transport processes (Newman and Reichenbach, 1996) . Hence, Müller cells are particularly important in ischemia when there is a massive release of transmitters from neurons (Hossmann, 1993) . Thus, the changes seen in the p75 immunoreactivity associated with the branches of the Müller cells in the inner plexiform layer after ischemia may therefore indicate changes in plasticity and be of functional significance (Vecino et al., 1998b) . Disorganization of Müller cell processes has also been observed in RP65 mutant dogs, in which the primary cells affected are photoreceptors, while in glaucomatous rat retinas the cells affected are RGCs. These changes within the Müller cells again demonstrate that Müller glia have a radial function in the retina that senses the changes in the outer as well as the inner retina, reacting by modulating the structure and possibly the function of retinal neurons.
Other trophic factors
Ciliary neurotrophic factor (CNTF) CNTF exerts numerous effects on the development, differentiation and survival of retinal neurons (Rhee and Yang, 2010) . The molecular mechanisms that explain the neuroprotective role of CNTF in the retina include: a direct action on photoreceptors to prevent apoptosis; the stimulation of Müller cells to produce photoreceptor survival factors (Zack, 2000) ; enhanced synthesis or distribution of glutamate transporters, thereby improving glutamate handling and resulting in less excitotoxic damage to retinal neurons (Escartin et al., 2006) ; and an induction of metabolic plasticity and increased resistance to metabolic damage (Escartin et al., 2007) . Defining the global transcriptional response of Müller cells to CNTF in vivo will help elucidate the molecular basis of its biological actions in the retina. CNTF induces rapid and extensive transcriptional changes in Müller cells and several genes induced by CNTF in normal Müller cells are also up regulated in gliotic Müller cells involved in inherited and experimentally-induced retinal degeneration. Hence, CNTF would appear to be an inducer of gliosis in the retina. Interestingly, the transcript profiles of Müller cells and astrocytes are similar although they are derived from distinct cell lineages (Xue et al., 2011) . Exogenous CNTF initially targets Müller glia and they trigger a reaction that induces the production of cytokines that act through gp130 in photoreceptors to promote neuronal survival (Rhee et al., 2013) . Indeed, CNTF not only reduces the death of photoreceptors but it also rescues retinal function (Heiduschka et al., 2013) . In addition, lens injury upregulates CNTF in retinal astrocytes and Müller cells.
bFGF is a pleiotropic cytokine that, in addition to its proangiogenic actions, may elicit further effects on retinal cells. bFGF is found in astrocytes, Müller cells, RGCs and RPE cells. Although bFGF is considered to be neuroprotective in the retina, it may also have detrimental effects by stimulating aberrant vessel growth, or inducing the proliferation and de-differentiation of Müller cells (Bringmann et al., 2009a) . Together, bFGF and VEGF act synergistically on microvascular endothelial cells (Yan et al., 2001) , whereby the effects of bFGF are in part mediated by stimulating VEGF release from Müller and vascular endothelial cells (Hollborn et al., 2004) . Müller cells represent a major source for bFGF in the ischemic retina and in diabetic fibrovascular tissue. The secretion of bFGF by Müller cells is stimulated by various pro-angiogenic growth factors and cytokines. Indeed, while the soluble factors released by Müller cells in response to transient hypoxia produce an anti-angiogenic environment for retinal vascular endothelial cells, persistent hypoxia increases bFGF release from Müller cells, which may become increasingly important to shift the balance between stimulators and inhibitors of angiogenesis in the retina. In such conditions Müller cells are likely to provide a stimulatory environment for the proliferation of retinal vascular endothelial cells and bFGF may play a key role in the stimulation of abnormal vessel growth in the retina (Yafai et al., 2013) . In diabetes, the increased formation of advanced glycation end-products (AGEs) in the vitreous humour may also be involved in the initiation and progress of intraocular NV through the production of bFGF by Müller cells .
PEDF (Pigment epithelium derived factor) Müller glial cells are PEDF producers, a positive trophic factor expressed by activated Müller cells. PEDF is a 50 kDa glycoprotein and it is upregulated by Müller cells following retinal hypoxia or injury. PEDF functions as an anti-oxidative and anti-inflammatory agent, as well as exerting neuroprotective and neurotrophic effects that are mediated by activation of the NF-kB (nuclear factor kappa B) and ERK1 and 2 pathways. When secreted by Müller cells, this factor acts directly on PEDF receptors at the surface of RGCs. The upregulation of PEDF in Müller cells occurs early in gliosis and it may reflect an attempt to rescue retinal neurons from further damage (Unterlauft et al., 2012) . Indeed, PEDF reduces RGC loss in DBA/2J mice, a mouse model of inherited glaucoma (Zhou et al., 2009) .
The expression of PEDF, Kir4.1 and GLAST by retinal Müller cells is unbalanced at high glucose concentrations, with abnormal expression closely related to oxidative stress. Decreased expression of PEDF induces a down-regulation of Kir4.1 in Müller cells, causing membrane depolarization of Müller cells and GLAST dysfunction. Thus, retinal PEDF must balance the anti-oxidative state against the need to protect retinal neuronal and glial cells (Xie et al., 2012) . Further evidence for the neuroprotective actions of Müller cell derived PEDF in the retina involves the intracellular signalling molecules that may operate in the RGC under conditions in which PEDF of glial origin exerts its pro-survival effects on RGCs. Thus, PEDF-induced NF-kB activation enables RGCs to protect themselves from hypoxia-or growth-factor deprivation-induced apoptosis. Although not directly demonstrated, exposing RGCs to PEDF may increase the phosphorylation of the inhibitor NF-kB, I-kB, thereby unmasking the NF-kB/NLS domain at the C terminus of NF-kB, stimulating its nuclear translocation and increased its DNA binding activity .
Insulin-like growth factor-1 (IGF-1) is a polypeptide growth factor similar in structure and function to insulin. IGF-1 has mitogenic, metabolic and growth-stimulating activities in many cells and tissues, including the retina, and it promotes the survival of various cells following serum deprivation. This protective effect of IGF-1 most probably occurs via PI3K/Akt, although the complete details of the upstream and downstream targets have not yet been elucidated (Guvakova, 2007) .
Glial Derived Neurotrophic Factor (GDNF) in the retina has been reported to rescue photoreceptor activity in the rd1 mouse model of Retinitis Pigmentosa (Frasson et al., 1999) and its effects are transmitted indirectly via activation of Müller glia (Harada et al., 2003; Hauck et al., 2006) . Transcriptome profiling of the mouse retina in response to GDNF identified osteopontin (OPN) as a novel GDNF effector that could in part mediate in the GDNF induced neuroprotective activity of Müller cells on photoreceptors (Del Rio et al., 2011) . OPN is secreted by Müller glia and it supports photoreceptor survival in explant cultures of rd1 retinas, potentially exerting a direct pro-survival effect on photoreceptors. OPN has a significant, concentration-dependent survival effect on primary porcine photoreceptor cells, and it activates the PI3K/Akt prosurvival pathway (Del Rio et al., 2011) . OPN also induces the release of VEGF, glutamate, ATP and adenosine from Müller cells. The effect of OPN was prevented by blockers of voltage-gated sodium channels (tetrodotoxin), T-type voltage-gated calcium channels (kurtoxin), potassium channels (clofilium) and chloride channels (5-nitro-2-(3-phenylpropylamino)-benzoic acid) (NPPB). The swelling-inhibitory effect of OPN was dependent on intracellular calcium signalling, the activation of PLC and protein kinase C, and vesicular exocytosis of glutamate. In retinal slices, Müller glial cells are immunoreactive for OPN and Müller cell-derived OPN has autocrine effects. The neuroprotective effects of OPN may in part be mediated by preventing the cytotoxic Müller cell swelling, and the release of VEGF and adenosine by Müller cells (Wahl et al., 2013) .
VEGF (see section on Gliosis above).
Phagocytosis
The phagocytotic activity of Müller cells was described more than eight decades ago. There is no evidence that these cells can phagocytise pathogens, however the phagocytotic properties of Müller cells were recently revaluated following Staphylococcus aureus infection. As a result, Müller cells can apparently not only phagocytise bacteria but they can also kill them intracellularly (Singh et al., 2014) .
Astrocytes play a role in the life cycle of axonal mitochondria at the head of the optic nerve. Optic nerve fibres discard their mitochondria, which are then engulfed by neighbouring astrocytes (transmitophagy: Davis et al., 2014) . In the myelination transition zone, astrocytes have a constitutive phagocytotic role and they express the phagocytotic marker Mac-2, which augments in glaucoma, and it may play an important role in axonal degeneration (Nguyen et al., 2011) .
The death of RGCs after optic nerve injury involves the participation of microglia/macrophages and astroglia in a neuroinflammatory scenario. Simvastatin, a statin used to lower blood cholesterol, may reduce NF-kB activation by TNF-a in astrocytes maintained in culture. When administered systemically, the drug suppresses RGC death possibly by ameliorating the astroglial reaction to injury (Morishita et al., 2014) . TNF-a can activate signalling reactions involving NF-kB or C-Jun N-terminal kinase (JNK) pathways. These pathways influence neurodegeneration and serve as neuroprotectors. The detrimental and neuroprotective role of TNF-a signalling was recently assessed in cultured RGCs and astrocytes (Dvoriantchikova and Ivanov, 2014) , apparently activating NF-kB and JNK in astrocytes but not in RGCs, indicating a contrast in both cell populations. However, the significance of this finding in vivo remains unclear. TNF-a also induces the secretion of MMP-2 by optic nerve astrocytes and this secretion is attenuated by a selective delta opioid agonist, SNC121 (Akhter et al., 2013) . Extracellular ATP acts as a ligand to purinergic receptors and P2X4 purinergic receptors (ionotropic receptors) are distributed in different cell types within the retina (bipolar cell terminals, horizontal cell somata and processes, calretinin-positive amacrine cells…etc), microglia, Müller cells and astrocytes. These receptors influence glia function and local tissue homeostasis in both physiological and pathological conditions (Vessey et al., 2014) .
Repair and regeneration
Retinal astrocytes and Müller cells both produce multiple factors that are trophic to RGCs, perhaps at different levels and under different conditions. RGCs express a number of receptors that respond to trophic factors including but not restricted to leukaemia inhibitory factor (LIF), CNTF, NGF, BDNF, IGF, neurotrophins, GDNF and FGF2 (Bonnet et al., 2004; Kinkl et al., 2003; Vecino et al., 1998b Vecino et al., , 2002 . However, promotion of RGC survival is only transient and does not necessarily correspond with the restoration of axonal outgrowth. In fact, whilst some of these trophic factors are very efficient at enhancing cell survival, some of them promote axonal growth , indicating that a delicate balance must exist to promote optimal RGC regeneration.
Reactive glia clearly display inhibitory properties, yet an intermediate "activated" glial phenotype may also exist that favours axonal regeneration by upregulating factors that enhance their growth and repair, whilst keeping inhibitory responses below the threshold for damage. Acute activation of glia is neuroprotective, while sustained activation is detrimental, for example due to the release of inflammatory cytokines. Enhanced reactivity or "activation" of retinal glia has positive effects on RGCs due to the production of trophic factors, both in vivo after injury and also in vitro.
Indeed, reactive glia secrete trophic factors distinct to those produced by quiescent glia and the degree of gliosis also appears to be crucial to determine the success of RGC regeneration.
Can retinal glia be primed to have positive or negative effects on RGC survival and regeneration? Müller cells secrete factors to the media that favour the survival, regeneration and branching of RGC axons in vitro Higginson et al., 2013) . Activation of rat retinal glia (astrocytes and Müller cells), either by lens lesion, intravitreal peripheral nerve grafting, zymosan injection or experimental glaucoma (Lorber et al., 2009 (Lorber et al., , 2008 (Lorber et al., , 2002 (Lorber et al., , 2012 , enhances the regenerative potential of RGCs in vivo and in vitro. It is assumed that retinal glia are activated by factors produced after lens injury or peripheral nerve graft, or by macrophages, which may be proteinaceous or non-proteinaceous, and that they are then stimulated to secrete neurotrophic factors that enhance the growth of RGC axons. A trophic factor produced by activated astrocytes and Müller cells that enhances RGC axonal regeneration is CNTF. Its production is mediated by apolipoprotein E (ApoE), which is upregulated in retinal astrocytes and Müller cells after optic nerve crush and intravitreal Zymosan injections (Lorber et al., 2009; Muller et al., 2007) . Other trophic factors produced by reactive retinal astrocytes and Müller cells that may be involved in RGC regeneration include BDNF, GDNF and bFGF (Bonnet et al., 2004; Garcia et al., 2002 Harada et al., 2000 , 2002Kinkl et al., 2003 .
Although mammalian Müller glia can respond to injury, proliferate and express genes that are associated with retinal stem cells (Roesch et al., 2008) , they do not function as retinal progenitors in vivo. Nonetheless, these characteristics suggest that under the right circumstances, Müller glia might act as retinal progenitors that can be used for repair. The regenerative potential of Müller cells makes them ideal candidates for cell replacement therapy to treat retinal degenerative diseases, such as age-related macular degeneration, retinitis pigmentosa or glaucoma, where loss of vision correspond to retinal neuron loss. A regenerative strategy that mobilizes the patients' own Müller progenitors to participate in retinal repair would have several advantages over cell transplantation therapy (Ruilin et al., 2014) . Indeed, in rodent and human cell cultures, Müller glia can generate both neurons and glia (Das et al., 2006) . Importantly, primary human Müller glial cell cultures can generate photoreceptors and RGCs that have some reparative potential when transplanted into a damaged rodent retina. These studies suggest that human Müller glia are capable of generating neurons under appropriate conditions and that they may be able to participate in repair. Indeed, human Müller glia stem cells (hMGSCs) can differentiate into functional RGC precursors in vitro, as confirmed by their expression of RGC markers and the increased cytosolic calcium in response to nicotinic stimulation (Singhal et al., 2012) .
Viral expression of ASCL1 is sufficient to activate a neurogenic program in mammalian Müller glial, both in dissociated cultures and in the intact retina. ASCL1 remodels the chromatin of retinal progenitor genes, activating their expression and downregulating glial genes. The reprogrammed Müller glial differentiate into cells that resemble neurons morphologically, both in terms of gene expression and in their responses to neurotransmitters. These results suggest that stimulating neurogenesis in Müller glial with ASCL1 could provide an alternative strategy for retinal repair after disease or injury (Pollak et al., 2013) . Similarly, manipulating the Ephrin-A2/A3 pathway may represent a viable approach to promote the progenitor cell fate of Müller cells, since Ephrin-A2 and A3 inhibit the regenerative potential of Müller cells in the retina of adult mice (Ruilin et al., 2014) .
Among the possible molecular and cellular mechanisms controlling neuronal regeneration, p53-mediated cell cycle arrest may play an important role in preventing Müller glia proliferation in the adult mouse retina (Ueki et al., 2012) . The loss of p53 activity could significantly enhance the proliferation potential of cells and facilitate the reprogramming of Müller glia into retinal progenitor cells (Zhao et al., 2014a) . The tumour suppressor p53 plays a fundamental role in astrocytes, when environmental conditions are deleterious, as in heightened conditions of oxidative stress. In "super p53" mice that carry two copies of the p53 gene, the density of astrocytes is greater than in the wild type and the area they occupy is also augmented (Salazar et al., 2013) .
Atoh7 is an essential transcription factor that determines the competence state of RGC progenitors. Ectopic expression of Atoh7 significantly increases the number of RGCs that differentiate from cultured retinal stem cells in vitro (Yao et al., 2007) . Moreover, Atoh7 promotes the differentiation of Müller cell-derived retinal stem cells into RGCs by inhibiting Notch signalling, opening up a new avenue for gene therapy and optic nerve regeneration in glaucoma (Song et al., 2013) .
Glutamate is the main neurotransmitter of the vertical signalling pathway in the retina and it induces the expression of progenitor cell markers in adult murine Müller glia, both in vivo and in vitro (Takeda et al., 2008) , as well as promoting the proliferation of Müller derived progenitor cells (Ramirez and Lamas, 2009) . Glutamate can trigger de-differentiation in primary cultures of rat Müller glial cells through a process that involves the activation of NMDA and group II metabotropic glutamate receptors, and to some extent the participation of global DNA demethylation via gadd45b (Reyes- Aguirre et al., 2013) .
Specific functions
Light guidance of Müller cells
In the mammalian retina, light has to pass the entire depth before it arrives at the photoreceptors suggesting that specific retinal tissue optics overcome light scattering, even in the typical non-foveate vertebrate retina. It has been proposed that Müller radial glial cells might act as light-guiding elements (Labin and Ribak, 2010) and that to minimize light scattering, non-foveal Müller cells act as living optical fibres that guide light through the inner retinal layers towards the photoreceptors, similar to glass fibre optics (Franze et al., 2007) . The funnel-shaped endfoot of Müller cells could serve as a light collector at the vitreal surface of the retina and the stem processes as light-guiding fibres. Between the vitreous and the retina there is a 'soft coupling' of the light path that reduces light reflection at the inner retinal surface (Franze et al., 2007) . Müller cells in the living retina minimize intraretinal light scattering, conserving the diameter of the beam that hits a single Müller cell endfoot. Thus, high intensity light reaches the individual photoreceptors. By minimizing scattering and enhancing the signal/noise ratio, Müller cells conserve the spatial distribution of light patterns in the propagating image. The ratio between the numbers of cones and Müller cells is roughly 1:1, indicating an optimal coupling between the light-guiding units and the functional light pattern-sensing units (the cones: Agte et al., 2011) . The molecular basis of the light-guiding capacity of Müller cells remains to be determined, although bundles of IFs are arranged along the light path. In tissue edema, the neuroretina loses its transparency and the milky opacity of the edematous tissue makes it likely that the light guidance through Müller cells is deteriorated, resulting in increased scattering .
Progenitor cells
Unlike neurons, glia have the lifelong capability to dedifferentiate and re-enter the mitotic cycle. Under pathological conditions, hypertrophy and the proliferation of glial cells leads to the formation of glial scars, which fill the spaces left by dying neurons and disconnected synapses . Müller glia in mammalian retinas can respond to injury, proliferate and express genes that are associated with retinal stem cells (Roesch et al., 2008) , displaying a gene expression profile resembling that of progenitor cells (Blackshaw et al., 2004) . A subset of Müller cells express progenitor genes like Car2, Dkk3, Chx10 and Pax6 (Roesch et al., 2008; Rowan and Cepko, 2004) , and Müller cells in the adult mouse retina express cell cycle genes like cyclinD3, Cdc14A, Cdk10 and Spbc25, as well as genes in the Notch pathway that might regulate the re-entry of Müller glia into the cell cycle under pathological conditions (Roesch et al., 2008) .
Müller glia might adopt characteristics of retinal progenitors that can be used to repair injured retina. In chicks (Fischer and Reh, 2001 ) and rats (Das et al., 2006; Ooto et al., 2004) Müller cells may even differentiate into cone and rod photoreceptors, raising the possibility that they may play a role as retinal stem cells. Indeed, primary human Müller glial cell cultures can generate photoreceptors and RGCs that have some reparative potential when transplanted into a damaged rodent retina (Jayaram et al., 2014) . Thus, Müller glia might be the ideal candidate for cell replacement therapy to treat retinal degenerative diseases where vision loss is caused by retinal neuron loss (Ruilin et al., 2014) .
Müller glia with stem cell characteristics have been identified in the adult human eye and although there is no evidence that they regenerate the retina in vivo, they can be isolated and grown in culture and can be induced to express retinal neuron markers in vitro (Lawrence et al., 2007) . Both hMGSCs and RGC precursors differentiate, as shown by the expression of RGC markers and the increase in cytosolic Ca 2þ in response to nicotinic stimulation (Singhal et al., 2012) , the former generating functional newly born RGCs in response to BMP, FGF2 and the secretase inhibitor (DAPT). This provides important evidence that hMGSCs can be differentiated in vitro into functional RGCs, providing a potential application in cell-based therapies to treat conditions in which RGCs are compromised (Becker et al., 2013) . In addition, an immortalized human Müller glial cell line (MIO-M1) has been established that can maintain its characteristics over 50 sub-culture passages (Limb et al., 2002) . Cell-derived micro vesicles (MVs: recognized as important components of cellecell communication) contain mRNAs, miRNAs, proteins and lipids, and they can transfer their bioactive contents from parent cells to cells of other origins. Embryonic stem cell microvesicles (ESMVs) induce de-differentiation and the pluripotency of Müller cells after prolonged exposure, opening an avenue to employ ESMVs in therapies to induce and support the retina's endogenous regenerative capacity (Katsman et al., 2012) .
The viral expression of ASCL1 is sufficient to activate a neurogenic programme in mammalian Müller glia, both in dissociated cultures and in the intact retina. The reprogrammed Müller glia differentiate into cells that morphologically resemble neurons, in both their gene expression and their responses to neurotransmitters. Hence, stimulating neurogenesis in Müller glia with ASCL1 could provide an alternative strategy for retinal repair after disease or injury (Pollak et al., 2013) . Manipulating the ephrin-A2/A3 pathway may also represent an alternative means to promote the progenitor cell fate of Müller cells (see above: Ruilin et al., 2014) .
Among the possible molecular and cellular mechanisms that control neuronal regeneration, p53-mediated cell cycle arrest may play an important inhibitory role in Müller glia behaviour in the adult mouse retina (Ueki et al., 2012) . Loss of p53 activity can significantly enhance the proliferation potential of cells and facilitate the reprogramming of Müller glia into retinal progenitor cells (Zhao et al., 2014a) . The tumour suppressor p53 may also strongly influence astrocytes (see above). The possible influence of Atoh7 and glutamate in promoting the generation and proliferation of Müller glia derived progenitor cells has also been addressed above.
Little is known about the role of BMPs in Müller glial proliferation although a novel role for BMP in the control of Müller glial proliferation was recently described. Treating the mouse retina with EGF stimulates the BMP signalling pathway in Müller glia, causing them to release BMP7. This autocrine BMP release activates the BMP receptors on Müller glia, promoting Smad1/5/8 phosphorylation and an increase in Id1. Hence, BMP can influence the mitogenic pathway regulating Müller glial proliferation, which has implications for both vitreoretinopathy and regenerative approaches to address retinal disease .
The capacity of some astrocytes to enter a re-programmed state of pluripotency and subsequently, to serve as progenitors capable of generating neurons suggests a reparative function that merits attention (Buffo et al., 2008; Wang et al., 2008; Wohl et al., 2012) In fact, the generation of neurons from astrocytes has been reported in vitro and it depends on specific transduction mechanisms mediated by key transcription factors like Pax 6 (Heins et al., 2002) or Mash 1 .
Heterogeneity of retinal glial cells
Astrocyte heterogeneity
The phenotypic heterogeneity among glial cell types is an emerging area of research in glial biology. Whilst most of the attention to date has focused on astrocyte subpopulations in the brain white matter (Chaboub and Deneen, 2012) , there is some evidence to support the existence of glial subpopulations within the adult mammalian retina. At least nine types of astrocytes with different morphological characteristics have been described in the normal brain. Moreover, morphologically undistinguishable astrocytes can exhibit different physiological behaviour (Matyash and Kettenmann, 2010) . The existence of different astrocyte populations is reinforced by the finding that astrocyte reactivity takes place in selected areas of the glaucomatous retina, these "microdomains" possibly serving as biomarkers and predictors of RGC health (Formichella et al., 2014) .
Astrocytes form a family of diverse populations adapted to their specific localization. Astrocytes in different brain regions have distinct physiological properties, and they express various sets of receptors and transporters, probably in response to their local environment. Within the retina the situation is similar and when primary retinal astrocytes are cultured, different types are evident that vary in their expression of neurotransmitters and molecular markers, and in their shape. For example, AQP4 is present in large amounts in the astrocyte plasma membranes when they are in contact with microvessels. AQP4 influences many process (the volume of the extracellular space, waste clearance, potassium buffering, cell migration and calcium signalling: Nagelhus and Ottersen, 2013) and significantly, its expression is altered in diabetic retinopathy (Qin et al., 2012) . Astrocytes may play a role in the transport of exosomes with different cargos between neurons (Edelstein and Smythies, 2014; Kawikova and Askenase, 2014) . In a laser-induced choroidal neovascularisation (CNV) model, retinal astrocytes release exosomes containing anti-angiogenic compounds that protect the eye from the deleterious effects of neovascularisation (Hajrasouliha et al., 2013) .
Differential expression of TrkA, the NGF receptor, led us to identify two sub-populations of astrocytes in the adult human and pig retina. While most astrocytes in the nerve fibre layer (NFL) express TrkA, a small population in the INL do not express this receptor (Ruiz-Ederra et al., 2003) . A separate study of adult human retinal astrocytes identified 3 different sub-populations characterized by the expression of GFAP and Vimentin; GFAPþ/Vimentinþ, GFAPþ/VimentinÀ and GFAPÀ/Vimentinþ (Perez-Alvarez et al., 2008) . The physiological significance of this, if any, is not yet known but these data provide further strong evidence for the heterogeneity of retinal astrocytes.
In addition to the two sub-populations of astrocytes showing distinct TrkA expression in the INL, we found another possible subpopulation of retinal astrocytes based on their function. Thus, only a subpopulation of astrocytes were able to take up Fluorogold injected systemically in the blood vessels of the optic nerve of pig eyes when incubated over night in oxygenated cultured medium. Given their morphology, we propose that these specialized cells are the functional "perivascular astrocytes" described previously in the human eye (Wolter, 1956) . These astrocytes are preferentially connected to blood vessels while the rest of the astrocytes in the NFL of the retina connect mainly with RGC axons (Fig. 11) .
Interspecies differences have been observed in the distribution of astrocytes, which is very similar in the pig and human where two types of astrocytes are found: stellate astrocytes that form cell clusters; and elongated astrocytes located in the NFL (Ruzafa et al., 2014) . By contrast, only stellate astrocytes are found in rodents. Interspecies differences in brain astrocytes have also been found and differences exist between rodent and human astrocytes in similar areas of the cortex, including differences in size, branching area and calcium waves (Oberheim et al., 2009) .
Müller cell heterogeneity
Little is known about the heterogeneity of Müller cells, although only 30% of the Müller cells in vitro express class II MHC antigen, suggesting that these might be involved in retinal immune reactions (Roberge et al., 1985) . In an attempt to define the transcriptome of Müller glia, certain genes were seen to be expressed heterogeneously among the Müller glial cells including common housekeeping genes like b-actin, b-2-microglobulin, heat shock protein 1 b and TATA box binding protein (Roesch et al., 2008) . It is clear that molecular differences exist in Müller cells because the homeodomain containing transcription factor Chx10 is expressed only in a subset of Müller glia (Rowan and Cepko, 2004) . Heterogeneous gene expression among Müller glial cells was observed over a large cluster, yet further characterization of the glial genes identified will be required to clarify the diversity among Müller glial cells and to shed light on their potential functional diversity (Roesch et al., 2008) . A comparison of the Müller glia transcriptome with that of other glial cell types in the CNS failed to reveal common clusters of gene expression (Bachoo et al., 2004) . This might be due to technical differences or it might reflect a distinct genetic constitution. However, the expression of some transcripts was common to Müller glia and other glial cell types, and some transcripts enriched in Müller glia are also enriched in astrocytes include peroxiredoxin 6, Basigin (also called CD147), caveolin, CD9 antigen, carboxypeptidase (Roesch et al., 2008) .
Isolated cells in vitro can respond to certain conditions by rapidly changing their protein expression and transforming to a proliferative phenotype. While vimentin remains stably expressed in these cells, GFAP expression, which is probably induced during their isolation from the intact retina, is rapidly lost in vitro (Fischer et al., 2004) . This is consistent with reports from the chick retina where only the sub-population of GFAP negative retinal Müller glia become proliferative following NMDA-induced retinal damage, possibly indicating that the primary retinal Müller glia represent only a glial subpopulation (Hauck et al., 2014) .
Other evidence for phenotypic diversity among Müller glia includes the variation in nestin expression in Müller cells after retinal detachment from adult rats (Luna et al., 2010) . A different postinjury response may be elicited in individual Müller cell populations and since nestin is a marker of immature Müller cells, perhaps sub-populations exist with enhanced regenerative properties. Furthermore, a gene expression analysis of Müller cells in a mouse model of retinitis pigmentosa revealed significant inherent heterogeneity amongst individual wild type cells, with further diversity amongst individual cells post-injury (Roesch et al., 2012) .
Heterogeneity in GS or GFAP expression was observed in primary Müller cell cultures from adult rat or pig, and cells expressing high amounts of GS or GFAP lie close to others that do not express these markers (Fig. 12) . This was evident in both pure glial cell cultures as well as in Müller-RGC co-cultures. In addition, RGCs prefer to grow on Müller cells that overexpress GS, their regenerating axons following a very precise path over the surface of Müller cells that contain GS and avoiding the surrounding cells without GS (Fig. 13) . This heterogeneity among Müller cells would perhaps also reflect different glialeneuronal interactions that may have neuroprotective effects on retinal neurons.
Reactive Müller cells upregulate GS, possibly as a neuroprotective mechanism to limit glutamate neurotoxicity (Gorovits et al., 1997) . Whilst this is not a direct interaction between glia and RGCs, it does represent an important effect of glia on RGC survival and retinal homeostasis.
Glia and retinal pathologies
Microglia perform valuable activities in the retina under physiological conditions by interacting with other cell populations in the retinal layers. Maintenance of homeostasis is a complex task in which all cells in a tissue participate. Likewise, when things go wrong due to trauma or disease, the community of retinal cells responds and collaborates to restore a healthy state. However, this cannot always be achieved and the damage may seriously and irreversibly affect retinal function. Indeed, many pathological conditions may alter the integrity of the retina. In the case of neurodegenerative diseases the role of microglia is variable, and both their pathogenic engagement and neuroprotective role are entangled (i.e.: capacities and limits). Thus, both these roles must be fully understood to adequately design external interventions aimed at preventing, alleviating or eliminating the damage (Prinz et al., 2011) .
Retinal damage results from the action of different etiological agents, such as elevated intraocular pressure, altered vascularisation, ageing, genetic defects. In different retinal neurodegenerative diseases the cell signals and changes, like the inflammatory responses, exhibit both similar and singular characteristics, and therefore, therapeutic interventions must be based on knowledge of the common and distinct patterns of the disease . The effect of a glial response contralateral to the damaged eye has been demonstrated and it is very possible that inflammation caused by the way to increase intraocular pressure with laser could be the cause of such contralateral reactions (Gallego et al., 2012; Ramirez et al., 2010; Rojas et al., 2014) . It is thus very important to pay attention to the inflammation caused in the different experimental models of eye damage since in addition to elevation of intraocular pressure, it is possible that other retina damage can be caused to the retina. 
Diabetic retinopathy
Diabetic retinopathy (DR) is a long term complication of type 1 and type 2 diabetes. In both the proliferative (angiogenesis observed) and non-proliferative (disrupted blood vessels detected) forms of DR, activation of a plethora of signalling pathways ultimately results in retinal damage and visual loss (Grigsby et al., 2014) . Dysregulated metabolites (including glucose, amino acids, lipids, amines, vitamins, minerals, etc) disturb the homeostasis of growth factors, neurotrophic factors, cytokines and adhesion molecules, consequently affecting capillary permeability and cell turnover. Therefore, many related and unrelated biochemical pathways are involved in the complex pathophysiology of DR (Ola et al., 2012) , which explains why a precise picture of the mechanisms related to the onset and progression of the disease is not yet clear. Moreover, individual genetic susceptibility and habits influence the development and morbidity of the disease, which may eventually lead to partial or total loss of vision as a consequence of retinal destruction and/or detachment (Grigsby et al., 2014) . Clearly, DR has an important inflammatory component, where microglia participate as both prey and enforcer, together with other retinal cell populations, including neurons, glial cells and reduced myeloid populations (for a review see (Grigsby et al., 2014) .
As a consequence of consistent high blood glucose levels in DR, AGE appear (molecules that are non-enzymatically glycated in the presence of aldoses), dyslipemia occurs and there is an increase in ROS that activates retinal microglia. As a result, the microvasculature, as well as other glia and neurons suffer damage (Fletcher et al., 2005; Grigsby et al., 2014; Wong et al., 2011) . Various experimental animal models of DR have provided useful information about the molecular events involved in the disease. Alloxan or STZ (streptozotozin) are toxic agents that specifically destroy pancreatic islet beta cells and induce diabetes (Larger et al., 1995; Mansford and Opie, 1968) , while Goto Kakizaki (GK) rats are a non-obese model for spontaneous type 2 diabetes developed by select breeding (Kitahara et al., 1978) . The retina of these experimental animals can be used to analyse the role of microglia, in vivo and in vitro: their migratory, secretory and growth activities, as well as their neuroprotective capacity. Also, human subjects can be used to study the disease, although with evident limitations.
Microglial activation in DR has been observed at early stages of this progressive disease and an increase in microglial density occurs in the GCL and NFL, with a decrease in the IPL. The alignment of microglial processes along the optic nerve is also disrupted . It is noteworthy that the precise mechanism(s) of glial activation in DR and other retinopathies are not fully understood. A few examples illustrate the specific and partial relevance of several actors. The accumulation of AGA (Amadori-glycated albumin), an AGE product in early DR induces TNF-a secretion by microglia (Ibrahim et al., 2011) . Moreover, in an experimental rat model of diabetes, activated microglia more intensely express TNFa and IL-1b mRNA, and interestingly, minocycline (a tetracycline antibiotic with anti-inflammatory activity) produces an approximate 50% decrease in the transcripts encoding these two cytokines (Krady et al., 2005) . Another agent analyzed in DR is aldose reductase (an enzyme that catalyzes the synthesis of polyols), which is activated in DR (Kinoshita, 1986) . Aldose reductase participates in the activation of retinal microglia and its inhibition or its genetic deficiency significantly reduces the inflammatory changes caused by microglia activation , ameliorating the degeneration of capillaries and the generation of superoxide anions found in DR (Tang et al., 2013) . The participation of signalling pathways related to the microglial adenosine receptor A 2A has also been documented (see Santiago et al., 2014) .
In cases of disease or trauma, astrocytes react and become activated Yang et al., 2014) , undergoing a series of changes (proliferation/migration, hypertrophy, GFAP expression, secretion of pro-inflammatory signals that include IL-6, MCP-1 and MIP-2alp) aimed at tackling the insult in cooperation with other glial cells (Nahirnyj et al., 2013) . As a consequence of astrocyte activation, RGCs receive both positive and negative signals, and the disturbance of the homeostatic scenario triggers the death of resident retinal cells. Astrocytes also respond to aggression and in diabetes for example, high glucose levels alter astrocyte inflammatory cytokine expression, activating NF-kB and increasing oxidative stress (Shin et al., 2014) . In glaucoma and other degenerative retinal diseases, oxidative stress and death by apoptosis are known features, as are astrocytic TNF-a/TNFR signalling, nuclear factor (NF-kB) activation, and p53 and caspase 3 upregulation Tezel et al., 2012) . In neurodegeneration glial activity also deteriorates.
Elevation of histone acetylation in Müller cells plays an important regulatory role in the inflammatory response during diabetes . It has also been proposed that in early phases of diabetic retinopathy, Müller glial activation does not contribute to neurodegeneration but that it may provoke neuroprotection against high glucose induced neurotoxicity through a mechanism involving phosphorylation of extracellular signal-regulated kinase 1/2, pERK1/2: (Matteucci et al., 2014) . Since in vitro high glucose stimulation of Müller cells increases VEGF secretion, the specific ERK1/2 inhibitor, U0126, blocked ERK1/2 phosphorylation and thus, impaired the Müller cells secretion of VEGF that is implicated in the development of diabetic retinopathy (Ye et al., 2010) . Thus, targeting ERK1/2 signalling in Müller cells, through the upstream signalling pathway or nuclear transcription factors of VEGF secretion, could represent a promising future treatment for diabetic retinopathy.
Glaucoma
Glaucoma encompasses several diseases that destroy RGCs and their axons in the optic nerve through apoptosis (Garcia-Valenzuela et al., 1995) , provoking progressive loss of the visual field and blindness (Mi et al., 2014; Quigley, 2011; Rieck, 2013) . The aetiology and pathophysiology of glaucoma is not well known, although several risk factors and mechanisms that influence the disease have been found. Among these factors, the elevation of intraocular pressure (IOP) is particularly important, while other factors have also all been associated with the disease, like: low diastolic ocular perfusion pressure (calculated as 2/3 mean arterial pressure-IOP), other ocular hemodynamic parameters, systemic diseases such as sustained high blood pressure or diabetes, ethnic group, age, myopia, migraine, the nutritional state of RGCs (Hernandez et al., 2009) .
Human glaucoma can be classified into three main categories: primary open angle glaucoma (POAG), primary closed-angle glaucoma (PCAG) and primary congenital glaucoma (PCG: Ahonen et al., 2014; Quigley, 2011) . Each of these has specific and common characteristics, related to alterations of the aqueous humour outflow and abnormalities in the anterior chamber angle (Ahonen et al., 2014; Liu et al., 2013) . The structural changes in the outflow system involve a thickening of the trabecular beam, cell death in the cribriform layer, accumulation of extracellular material and plaque formation (Fuchshofer et al., 2006; Rohen et al., 1981) . However, a clear relationship between elevated IOP, structural alterations to the Schlemm's canal cells that respond to local mechanical changes, and the preponderant intervention of the mechanisms related to the onset and progression of the disease are not yet fully known (Galdos and Vecino, 2011; Overby et al., 2014; Vecino et al., 2015a) Interestingly, therapies that lower IOP slow the progress of different types of glaucoma, yet other treatments aimed at avoiding cell death are required.
Due to the limitations faced when studying human individuals, animal models of induced or spontaneous glaucoma are efficient tools to discover and define the aetiological factors, pathological mechanisms, and the extent and consequences of RGC death. Moreover, reliable animal models are needed to assess the therapeutic value of drugs in preclinical trials (Smedowski et al., 2014) . However, since differences in retinal anatomy and physiology between animal species exist, and the procedures used to obtain such experimental models may vary, it is necessary to ascertain the advantages and limitations of a particular model, and carefully choose the pertinent one in function of the damage caused to the optic nerve and the reproducibility (Smedowski et al., 2014; Vecino, 2008) .
Neuroinflammation is a common aspect of many neurodegenerative diseases, including glaucoma, and microglia participate in their pathology, although the precise extent to which they influence each disease is not yet clear. Microglial activation has been observed both in eyes affected by ocular hypertension and in the healthy contralateral eyes (Rojas et al., 2014) , indicating complex mechanisms are at play that involve both structural and diffusible elements. Microglial fractalkine may be a key element of the neurotoxicity exerted by microglia in an experimental model of induced glaucoma since suppression of its CX3CR1 receptor induced more extensive RGC death when IOP was elevated . A relationship between the release of cytokines (IL-6, IL-1, TNF-a, etc) and the initiation of apoptosis has been established (Gonzalez-Scarano and Baltuch, 1999) . The intervention of neurotoxic agents, alone or in collaboration, has been studied in vivo and in vitro, in different animal models or in humans. Thus, while there is abundant information, the immune system is complex, making it difficult to define the main causes and the accompanying phenomena. RGC death in glaucoma probably depends on the concurrence of several stressors (for instance ROS, glutamate, mitochondrial impairment…), as well as ill-tuned or adapted cellular responses (Rieck, 2013) . Thus, full resolution of this "puzzle" will require more effort.
Gene expression dependent on TGF-b2 activation in astrocytes cultured from the optic nerve head is reduced after antioxidant treatment, indicating that antioxidants may have a place in the treatment of neurodegenerative diseases like glaucoma (Yu and Welge-Lussen, 2013) . Astrocytes undergo morphological changes related to the damage produced in RGCs (Lye-Barthel et al., 2013) . Hypertrophia of astrocytes was observed in the optic nerve in a rat in vivo model of transient intraocular hypertension, as was early up-regulation of phosphorylated STAT3 (signal transducer and activator of transcription protein 3), a key transcription factor that regulates the expression of many genes and that may play a crucial role in the activation of astrocytes after an increase in IOP . Indeed, it is proposed that the damage observed in optic nerve axons after an increase in IOP is secondary to the damage induced in astrocytes, which suggests they are the primary site of damage in early stages of glaucoma (Dai et al., 2012a) .
In a mouse model of hereditary glaucoma (DBA/2J), an increase in BDNF in hypertrophic astrocytes was concomitant with a deficit in anterograde axonal transport prior to RGC synapse loss (Crish et al., 2013) . Hence, astrocytes may respond to the diminished axonal transport by taking up BDNF from target neurons to minimize the damage. It is very possible that the same mechanism will work at the onset of glaucoma and that after the first days of high IOP, the homeostatic mechanisms in the retina will be altered and glial cells will then orchestrate the events that will provoke the death of certain RGCs. It is unclear why not all RGCs die at the same time in Glaucoma, however, the glial environment of the vulnerable RGCs may be different and thus, these RGCs might respond to the malevolent signals in a more aggressive manner.
In rats where glaucoma was induced by cauterization of episcleral veins, in addition to RGC death changes in amacrine and bipolar cells were found, as well as astrocyte activation in the damaged but not the contralateral eye (Hernandez et al., 2010) . The function of astrocyte and Müller cell activation is unknown as yet, although one week after the IOP elevation we observe more astrocyte gliosis that decreased thereafter (Hernandez et al., 2010) . It is possible that the astrocytes detect the increase in pressure directly, or through microglial or Müller cells, and they react by liberating neurotrophic signals that could help RGCs to resist the insult. It is also possible that glial cells may provide mechanical support. Another possible function of reactive astrocytes might be related to repairing the damage to the blood retina barrier (Bush et al., 1999; Voskuhl et al., 2009 ). However, the detrimental side of astrogliosis is that reactive astrocytes may potentially exacerbate the glaucomatous process by overexpressing toxins, producing a direct toxic effect on RGCs. Müller cells overexpress GS, especially in their inner and outer regions, while the vimentin cytoskeleton is also partially disorganized (Fig. 14) . AQP9 expression is reduced in RGCs of glaucomatous eyes, while glaucoma induces AQP7 expression in the Müller cell endfeet. Alternatively, the expression of both AQP7 and AQP9 is reduced in the ciliary body of glaucomatous eyes. Therefore, AQP expression seems to play some role in glaucoma (Tran et al., 2014) .
Under normal conditions, resident macrophages maintain tissue homeostasis by removing dead cells and other debris, and by producing growth factors. However, under noxious conditions the cellular stress response is activated that results in cellautonomous adaption. However, communication between stressed cells and other cells in a tissue may also occur, including resident macrophages. If the nature or the extent of stress is such that it affects not only individual cells but also the entire tissue (e.g. hypoxia or hyperthermia), then a tissue-level stress response or parainflammation is elicited by the resident macrophages. Depending on the strength of the noxious conditions, this response can involve the recruitment of different types of circulating inflammatory monocytes. Parainflammation may also involve the mild release of plasma components into the affected tissue and if the condition is sufficiently severe (e.g., infection or injury), an acute inflammatory response ensues. This is characterized by the recruitment of neutrophils and specialized subsets of monocytes from the circulation that help to protect the host from infection, promoting tissue repair and restoration of homeostasis (Medzhitov, 2008 (Medzhitov, , 2010 . This could be the case of experimental damage to the eye where strong inflammation could activate resident cells and the immune system. Since astrocytes and microglial cells have receptors for inflammation, this could explain the contralateral response to damage in experimental models of hypertension when laser damage causes intense inflammation of the eye. It could also be relevant to situations in humans where inflammation of different sources (uveitis, trauma, etc…) could activate the immune system and affect the contralateral eye. We must pay close attention to the different experimental models to induce hypertension and glaucoma (RuizEderra et al., 2005; Vecino and Sharma, 2011). Vimentin (C, D) and glutamine synthetase (E, F) immunoreactivity (red) is evident in Müller cells. Nuclei were DAPI labelled (blue). Note the change in vimentin expression that is more disorganized (D) than in the control eye (C) and GS expression is increased in F with respect to the control eye in E. Scale bar ¼ 50 mm.
Age-related macular degeneration (AMD)
Advanced age is a risk factor for numerous pathologies, collaborating with other intrinsic and extrinsic cues that provoke the initiation of a given disease. The brain and the retina suffer agerelated deterioration/degeneration (Harry, 2013) , and to discover the importance of age in this process, which cannot be avoided or changed, it is paramount to unravel the influence of the other main aetiological elements (for example life-style and environmental factors) on the initiation and progression of neurodegeneration. Microglia populate the retina early in the embryonic period and their persistence during adulthood depends on self-renewal through multiple divisions (Ginhoux et al., 2010) . Microglial senesce has been observed in healthy aging rats in conjunction with telomere shortening and reduced telomerase activity (Flanary et al., 2007) . Other observations indicate that old microglia suffer agerelated alterations in their dynamic capacities (motility, branching, length of processes, etc.) and that they are less responsive to external stimuli like ATP (Damani et al., 2011) . Hence, the homeostatic role of microglia can be seriously altered with age (Karlstetter and Langmann, 2014) .
AMD is a neurodegenerative disorder in which age plays a principal role. The most common form of this disease is the atrophic or "dry" form that is characterized by RPE degeneration and central retina photoreceptor death. In the exudative or "wet" form, choroidal neo-vascularization is observed (Ma et al., 2009; Zhao et al., 2014b) . In healthy retinas, microglia are located in the inner retina and they are scarce or non-existent in the outer retina and retino-choroidal zone. However, in AMD the distribution of microglia changes dramatically. Activated microglia migrate to subretinal locations and in some cases, they come into close contact with drusen deposits (Ma et al., 2009 . In an in vitro model where microglial cells were co-cultivated with primary RPE cells and in an in vivo mouse model where microglia were transplanted into the sub-retinal space, microglia appear to be responsible for early alterations to RPE cells, and the initiation of a proinflammatory and pro-angiogenic environment (Ma et al., 2009) . Therefore, the translocation of microglia to the outer retina may be an essential event that triggers chronic inflammation related to the progress of AMD.
Genetic models provide valuable information to analyse the pathology of age-related neurodegeneration and to study the participation of microglia in such processes (Karlstetter et al., 2010) . For example, knock-out mice develop some characteristics of AMD at old ages, such as Ccl2 (CCL2 is a chemokine) and Cx3cr1 deficient animals, and the Ccl2/Cx3cr1 double knock-out developed evident lesions consistent with AMD earlier: RPE atrophy, photoreceptor death, neovascularisation, and migration of microglia to the outer nuclear layer and sub-retinal spaces (Tuo et al., 2007) . In a knockout mice deficient in Nrf2 (nuclear erythroid 2-related factor e a transcription factor that regulates the expression of protective proteins against oxidative stress), the abnormal presence of microglia, regulatory T cells and IL-17 (interleukin 17) producing T cells in the retina and at sub-retinal locations has been documented (Zhao et al., 2014b) . Therefore, the destruction of the RPE in early AMD favours the infiltration of circulating blood cells that contribute significantly to the pathology and progression of AMD. The AhR (a nuclear aryl hydrocarbon receptor) signalling pathway is a defence mechanism that detoxifies metabolic waste molecules and xenobiotics, and its activity in human RPE cells diminishes with age (Hu et al., 2013) . A knock-out mouse model deficient in AhR (Ahr À/À ) exhibits phenotypic characteristics of AMD, indicating that this signalling pathway may hinder the appearance of AMD (Hu et al., 2013; Kim et al., 2014) . Accordingly, a complex collaboration of mechanisms dependent on immune competent cells and RPE cells appears to be responsible for the initiation and progression of AMD.
Retinitis pigmentosa (RP)
RP is a group of heterogeneous inherited diseases in which the primary defect affects the retina, alone or in association to other anomalies affecting different organs. RP is characterized by photoreceptor degeneration and progressive blindness, yet the molecular and cellular mechanisms involved in photoreceptor death are not completely understood. Only when the mechanisms underlying this damage are known can effective treatments follow. As in other retinal pathologies, inflammation plays a fundamental role in RP and it has been associated with mutations that affect more than 70 genes related to different retinal functions (phototransduction, cell cycle proteins, ciliary proteins, structural proteins, transcription factors, see RetNet at https://sph.uth.edu/ retnet/disease.htm). However, in some cases the genetic defect is yet to be defined. Recently, a dominant mutation in the gene that encodes HK1 (hexokinase 1, an enzyme that catalyzes the phosphorylation of glucose in the glucolytic pathway) was found to cause RP (Sullivan et al., 2014) .
Microglia sense the environment and they rapidly respond to disturbances by trying to protect neurons against insults (neuroprotection). However, the persistence of damage may activate the neurotoxic phenotype of microglia, in an attempt to limit the damage (Langmann, 2007) . The early intervention of microglia in degeneration suggests that they play an active role in pathological mechanisms. In vitro and in vivo studies have characterized microglial behaviour in RP and other degenerative retinal diseases by studying their temporal transcription profiles, secretomes, phenotypic changes and migration (Karlstetter et al., 2010; Langmann, 2007) . Using genetic mouse models and in vitro approaches, the complex and multiple effects of microglia as key elements in RP and other examples of inherited retinal degeneration can be illustrated. An analysis of microglia transcripts and morphology in a retinoschisin-deficient mouse that suffers a severe photoreceptor dystrophy indicated that microglia act in early stages of the diseases (Gehrig et al., 2007; Karlstetter et al., 2010) . In a mouse RP model, rd (carrying a spontaneous defect in the b subunit of rod cGMP-phosphodiesterase), early activation of microglia was again seen by analysing the expression of microglial chemokine transcripts and the secretion of TNF-a, which appeared prior to or concomitant with photoreceptor death (Zeng et al., 2005) . Microglia-mediated neurotoxicity in photoreceptors is also supported by the activation of microglial NADPH oxidase, which generates ROS (Zeng et al., 2014) . When the rd10 mouse model of RP is crossed with a Cx3cr1 GFP/GFP mouse, microglial activation was evident as an early phenomenon in RP and Cx3cl1/Cx3cr1 signalling significantly ameliorated microglia neurotoxicity . Moreover, administration of minocycline for several days inhibited microglia activation, reducing photoreceptor death and improved vision in rd10 mice . Chemical destruction of microglia in rd10 mouse retinal explants with clodronatecontaining liposomes slowed photoreceptor death, yet the neuroprotective effect of IGF-I was attenuated when microglia were depleted. These findings suggest a misbalance in the microglial neuroprotective/neurotoxic intervention in this retinal dystrophy (Arroba et al., 2011 (Arroba et al., , 2014 . In a rat model of RP bearing a mutation in the rhodopsin-encoding gene (P23H), microglial cells were more abundant in all retinal layers and they were also present in the subretinal space. Treatment of these rats with taurodeoxycholic acid prevented microglial activation and delayed photoreceptor death (Noailles et al., 2014 contrast, CRALBP did not show an initial increase and it was expressed below control levels in adult mutant dogs. It is clear that Müller cells respond to outer retinal disease. The response was mild, transient and more intense in the younger than in the older mutant retinas, possibly indicating a lack of progressive retinal degenerative changes in the period analyzed. However, only a limited number of antibodies were analysed, two of which were directed at IFs. It is possible that other proteins (e.g., GC and carbonic anhydrase C) would respond differently as they are known to decrease in experimental retinal detachment in adult cats (Lewis et al., 1994) . Therapeutic approaches in RP and other hereditary diseases involving retinal degeneration might aim to restore the gene defect by gene-replacement (Beltran et al., 2014) or stem-cell transplantation (He et al., 2014) . Retinal degeneration might also be palliated or slowed by controlling the neuroinflammatory framework. This can be achieved with either immune-suppressant or immunomodulatory drugs (Karlstetter et al., 2010) . Another strategy includes the administration of protective molecules, such as rod-derived cone viability factors, to preserve cone-dependent central vision after rod death (Leveillard et al., 2014) . In addition, the application of sub-retinal photovoltaic arrays that restore photoreceptor function can be applied when the inner retinal circuits are preserved (Light et al., 2014) . Indeed different therapeutic approaches should target the specific features of each type of RP and hereditary retinal degeneration.
In diseases where the outer part of the retina is affected, Müller cells sense the damage in the outer retina and transmit the information to the inner retina. This event can be studied in dogs carrying a mutation similar to Leber Congenital Amaurosis (LCA), a specific type of RP. This disease comprises a group of childhoodonset, autosomal recessive retinal diseases that result in severe visual impairment or blindness (den Hollander et al., 2008) . LCA is caused by mutations in the RPE65 gene, which encodes the 65 kDa RPE-specific isomerase involved in visual pigment regeneration (Gu et al., 1997) . The RPE65 protein is essential to maintain retinal function and photoreceptor viability, and for retinoid cycling between the RPE and photoreceptors (Saari, 2000) . Mutations in RPE65 occur naturally in dogs (Aguirre et al., 1998) , and gene therapy studies in these dogs (Acland et al., 2001 ) has led to the first gene therapy undertaken in humans (Hauswirth et al., 2008) . We studied the molecular changes that take place in the retina of the mutant dogs as they mature (Hernandez et al., 2010) and found activation of astrocytes in the GC layer, even when the damage to the retina originated in the RPE. Hence, Müller cells appear to sense the changes in the outer part of the retina and communicate these to cells located in the inner part of the retina. Moreover, astrocytes located in the neighbourhood of RGCs may also sense that synaptic transmission was disturbed and react to this malfunction. Interestingly, after gene therapy with an adeno-associated virus to restore the mutated RP65 gene (AAV_RPE65), and even when functional recovery was achieved (Acland et al., 2001) , the glial cells remained activated 6e24 months after treatment (Fig. 15) . Only the CRALBP immunoreactivity in the RPE returned to normal levels after gene therapy, while Müller cells remained activated, as evident by examining vimentin labelling. Müller cells can change the morphology of their membranes, adapting to the changes in the damaged cells surrounding them. After this damage and retinal function is restored, as is this case with this gene therapy, Müller cells should return to the original state in a plastic-like process, although has yet to be confirmed (after the submission of this review and during the process of revision a book on retinal glia appeared where details of each cell type are addressed: Reichenbach and Bringmann, 2015) .
Conclusions, remarks and future directions
The retina contains three major classes of glia, Müller cells, astrocytes and a resident subpopulation of microglial cells. All are integrated with the neurons that form the retina and allow a correct functioning of the retina. Müller cells, astrocytes and microglia are all capable of phagocytosis, responding to immunological damage and they interact with neurons, thereby modulating the synapses. Moreover, the three cell types play a role in the metabolism of neurons, which is affected by their distribution and physiological state. Since the neurons in the retina are highly specialized, their metabolic demands are also very specific, and glial cells surrounding these neurons provide different nutrients. Therefore, it is crucial that when exploring the changes within the retina, an integrated approach should be adopted that considers glialeneuron interactions, in order to fully understand the retina in health and disease.
The source and age of glia is an important factor when determining the support that astrocytes or Müller glia can offer to RGCs. Much of the research concerning the molecular mechanisms of RGC processing in association with retinal glia has been carried out using embryonic tissue, the rational being that axon outgrowth during development could provide insight into the deficits underlying unsuccessful adult regeneration. Whilst much information can be gleaned from these studies, there are limitations to the comparisons that can be made, since there is a wealth of evidence showing that adult RGCs and glia have a highly altered molecular repertoire when compared to their embryonic and postnatal counterparts. Therefore, it is imperative that attention is paid to study adult RGCs and adult retinal glia.
The other limitation to studies in early periods is the use of astrocytes from non-retinal sources. We are now only just beginning to understand the complexity of glial heterogeneity and the roles of different subpopulations within a single tissue, and further research on the adult retina is required to explore the possibility that some populations of retinal glia are more supportive of RGCs than others. The molecular changes that take place in the adult retina after damage occur rapidly, within minutes or hours. However, the return to a normal situation can take years, although some restoration of function can be achieved in a shorter period.
